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The re-emergence of Zika virus (ZIKV) in 2015 as a significant human pathogen
causing neurological diseases in infants as well as adults is a serious global health
concern. A clear understanding of the mechanisms involved in ZIKV replication in
infected host cells as well as the host responses to virus infection are keys to the
development of therapeutic strategies against ZIKV. Studies conducted in this
dissertation demonstrate that ZIKV infection induces the activation of mTOR signaling
cascade that promotes viral protein accumulation and infectious progeny production.
While both mTORC1 and mTORC2 are essential for ZIKV replication, the observation
that depletion of Raptor, the unique component of mTORC1, imposes a robust negative
effect on ZIKV protein expression and progeny production also suggests a mTORindependent role played by Raptor. Additionally, the activation of autophagy at early
times of infection indicates an antiviral role for autophagy in ZIKV infection. The
observation that pharmacological inhibition of autophagy led to increased accumulation
of ZIKV proteins further strengthens this contention. Since infection-induced oxidative
stress contributes to ZIKV pathogenesis, studies reported in this dissertation also show
that ZIKV infection alters the redox homeostasis in infected cells and triggers Nrf2mediated antioxidant response. Depletion of Nrf2 downregulates the cellular pool of GSH

and NADPH leading to enhanced ZIKV replication thereby underscores a role for cellular
antioxidants in the suppression of ZIKV replication. The dependency of ZIKV replication
on host cell glycolysis is highlighted by significant reduction in viral protein expression
and virus yield due to pharmacologic inhibition. When glycolysis is inhibited,
gluconeogenesis was found to facilitate ZIKV replication by compensating carbon input
via oxidative mitochondrial metabolism. Further experimentation comparing the
metabolic profiles of mock- and ZIKV-infected cells may provide important information
in understanding the role of cellular metabolism in virus replication.
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CHAPTER 1: INTRODUCTION

1.1 Zika virus (ZIKV): Discovery, history, and re-emergence
In 1947, scientists isolated a filterable and previously unrecorded virus from the
serum of a pyrexial rhesus monkey in the Zika forest of Kampala, Uganda (Dick et al.,
1952). The following year, in 1948, a second isolation of the same virus was made from
Aedes africanus mosquitoes (Dick et al., 1952). Cross neutralization tests showed
evidence of a novel virus that was not identical to yellow fever virus (YFV) or Theiler's
mouse encephalomyelitis virus that were prevalent in that region. Owing to the location
of its discovery, this novel virus was named Zika virus (ZIKV) (Dick et al., 1952; Musso
and Gubler, 2016). While seropositivity in humans was reported in Tanzania and Uganda
in 1952, the first case of human infection with ZIKV was reported in 1954 in Nigeria
(Macnamara, 1954; Musso and Gubler, 2016). The virus was isolated from Aedes aegypti
mosquitos in Malaysia in 1969 and the first case of human infection outside of the
African continent was reported in Central Java, Indonesia (Musso and Gubler, 2016).
Since its discovery, only about 14 cases of human infection were reported in Asia and
Africa (Kindhauser et al., 2016; Musso and Gubler, 2016; Sharma et al., 2017) (Fig. 1.1).
After almost 60 years, in 2007, the virus re-merged and about 72.6% of the population
was infected causing a major epidemic in the Yap Island of Federated States of
Micronesia (Kindhauser et al., 2016). A second outbreak affecting about 11.5% of the
population occurred in 2013 in French Polynesia. Additional smaller outbreaks also
occurred in other Pacific Islands such as New Caledonia, Cook Islands, and Easter Island
in 2013-14 (Cao-Lormeau et al., 2014; Musso and Gubler, 2016; Musso et al., 2014). In
2015, ZIKV caused an outbreak of epidemic proportion in Brazil and rapidly
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Figure 1.1: Global presence of ZIKV. A Worldwide spread of ZIKV from 1947 to 2016
(Image sourced from Lessler et al, 2016). B ZIKV in the USA and its territories:
Numbers of laboratory-confirmed symptomatic Zika virus infections reported to
ArboNET by US states and territories as of 2017 and C 2021. ZIKV infections in the US
and its territories have significantly declined in the past three years [Image sourced from
the Centers for Disease Control and Prevention (CDC), National Center for Emerging
and Zoonotic Infectious Diseases (NCEZID), Division of Vector-Borne Diseases
(DVBD) ].
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spread the Americas and other parts of the world (Kazmi et al., 2020; Zanluca et al.,
2015). In the United States of America, the Center for Disease Control and Prevention
(CDC) reported about 5,746 symptomatic infections till 2019 with most of them
associated with travelling to places where ZIKV was actively spreading. The CDC also
reported about 37,000 cases in US territories (Fig. 1.1). Globally, the virus has been
reported in more than 84 countries and the recent outbreaks in the Americas have been
associated with increased instances of Guillain-Barré Syndrome (GBS) in adults and
microcephaly in neonates (Maslow and Roberts, 2020). Although only a few cases of
transmission of ZIKV have been reported since 2017, it has the potential to cause major
outbreaks in the future (Musso et al., 2019).

1.2 ZIKV: Classification
ZIKV belongs to the family Flaviviridae and genus flavivirus. The Flaviviridae
family consists of four genera: Flavivirus, Pestivirus, Hepacivirus and Pegivirus (2017).
The genus Flavivirus comprises of over 70 arthropod-borne viruses. Further classification
of flaviviruses is based on the arthropod vector utilized by them. Viruses like ZIKV,
Dengue virus (DENV), Yellow Fever Virus (YFV), Japanese Encephalitis (JEV) and
West Nile virus (WNV) are transmitted by mosquitoes (Kuno et al., 1998). Viruses like
Kyasanur Forest Disease virus (KFDV), Tick-borne Encephalitis virus (TBEV), Omsk
Hemorrhagic Fever Virus (OHFV) and Alkhurma virus (ALKV), which are responsible
for encephalitis and hemorrhagic diseases, are transmitted by ticks.

1.3 ZIKV: Virion structure

5

The cryo-EM structure at near atomic resolution (3.8Å and 3.7Å) of ZIKV was
solved by two independent groups and was found to be consistent with other closely
related flaviviruses such as DENV and WNV (Kostyuchenko et al., 2016; Sirohi et al.,
2016). As depicted in Fig. 1.2, the immature virion is ~60nm in diameter while a mature
ZIKV particle is ~50nm in diameter (Kostyuchenko et al., 2016; Prasad et al., 2017;
Sirohi et al., 2016; Sirohi and Kuhn, 2017). The viral genome is a single-stranded,
positive-sense and non-segmented RNA of about 11 kilobases and is encapsulated by the
viral capsid protein and the host derived lipid bilayer (Boyer et al., 2018) (Fig. 1.2).
A mature ZIKV virion contains 180 copies of the viral E and M proteins that are
embedded in the host derived lipid membrane (Sirohi and Kuhn, 2017). The E protein
consists of 4 domains, namely, ectodomains I, II and III (DI, DII, DIII) and a stemtransmembrane domain. The surface of the virion is covered by the E protein while the M
protein resides beneath the E protein and is attached by a small extra-cellular region
(Sirohi and Kuhn, 2017). The E protein is organized as a dimer and 3 such dimers are
arranged in parallel to form a raft configuration. There are 30 rafts in a single ZIKV
particle (Sirohi and Kuhn, 2017). ZIKV does not exhibit the usual T=3 quasi-equivalence
even with 180 units of E and M proteins arranged in a raft configuration. This is because
of the unusual arrangement of the E protein (Sirohi and Kuhn, 2017).

1.4 ZIKV: Genome organization
The infectious genome of ZIKV is a single-stranded, positive-sense RNA of about
11 kb in length and is arranged in the following order: 5’ untranslated region (UTR), a
single open reading frame (ORF) and the 3’ UTR (van Hemert and Berkhout, 2016). The
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Figure 1.2: Structure of Zika virus particles. Immature and mature ZIKV particles.
Proteolytic processing of prM protein, by host protease furin, in the immature noninfectious virion A results in the generation of mature, smooth-surfaced, infectious
particle B. The immature particle contains 60 trimers of prM-E heterodimers, while the
mature particle contains 90 conformationally rearranged heterodimers of M-E (Images
were adapted from Sirohi, D. and Kuhn, R.J. (2017)). C Schematic representation of a
prototypical flavivirus (including Zika virus) immature and mature particle showing a
cross-sectional organization of viral proteins and RNA. sE, soluble E protein [Image
sourced from Heinz, F.X. and Stiansy, K. (2017)].
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5’ UTR is ~106 nucleotides long and has a type I cap (m7GpppAmp) structure at the 5’
terminus and is followed by conserved AG dinucleotide (Brinton and Dispoto, 1988). The
3’ UTR comprises of ~430 nucleotides and does not have a poly A tail but ends with
consists of conserved CUOH at the 3 ’-terminus (Brinton et al., 1986) (Fig. 1.3).
The ORF is ~10.2 kilobases and is translated into a single polypeptide of ~3400
amino acids in the cytoplasm of an infected cell (Chambers et al., 1990). The single
polypeptide is processed and cleaved by proteases of host as well as viral origin and
results in three amino-terminal structural (capsid, C; pre-membrane, prM; and envelope,
E) proteins and seven carboxy-terminal non-structural (NS1, NS2A, NS2B, NS3, NS4A,
NS4B, and NS5) proteins (Kuno and Chang, 2007) (Fig. 1.3). As in other flaviviruses
like DENV, WNV, YFV and JEV, the structural proteins are responsible for virus
attachment and entry into host cells, and virion formation while the non-structural
proteins aid in genome replication, polypeptide processing, evasion of host antiviral
defenses and virion assembly (Diamond and Pierson, 2015; Kumar et al., 2016).

1.5 ZIKV: Structural proteins
1.5.1 Capsid (C) protein
The C protein is 104 aa in length and has a molecular weight of ~14 kDa (Shang
et al., 2018). Following translation, the protein relocates to the cytoplasmic side of the ER
and helps in the translocation of the viral prM protein into the ER lumen (Byk and
Gamarnik, 2016; Tan et al., 2020). It has an overall positive charge and associates with
the negatively charged genomic RNA forming the nucleocapsid core which gets
incorporated into new virions (Shang et al., 2018; Tan et al., 2020). It has been shown to
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Figure 1.3: ZIKV genome organization, encoded proteins, and their topology. A The
viral genome is shown as a red line with a cap structure at the 5’ end, followed by an
untranslated region (5’UTR), various proteins (with amino acid residue length) generated
from a single ORF that is translated from the genome, and the 3’ UTR. B Topology of the
viral proteins. Arrows show various protease cleavage sites for generation of the mature
proteins. A small protein (2K) present between NS4A and NS4B is membraneassociated. The cylindrical structures represent membrane-associated domains of the
proteins (Image redrawn from Tan et al, 2020)
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play a vital role in the process of virus assembly and is responsible for the overall
icosahedral structure of the virus particle (Tan et al., 2020). Additionally, the capsid
protein is known to translocate into the nucleus of the infected cells and interfere with
ribosome biogenesis and alter host transcriptome (Sotcheff and Routh, 2020).

1.5.2 Precursor membrane (prM) and membrane (M) proteins
The prM protein is a glycosylated protein of 168 aa in length (Kuno and Chang,
2007). Post synthesis, the prM protein relocates into the ER where, and in association
with the viral envelope protein, forms immature virions and acts a chaperone for efficient
and proper folding of the envelope protein (Lorenz et al., 2002; Nambala and Su, 2018;
Nambala et al., 2020). The prM protein is cleaved by cellular furin protease in the transgolgi network and results in pr peptide and the M protein (Hsieh et al., 2011). The pr
peptide associates with the envelope protein and helps in egress of mature virus particles
(Oliveira et al., 2017). Recent studies suggest that the prM protein plays a significant role
in increased neurovirulence and the development of microcephaly in mice (Yuan et al.,
2017). The study also found that a serine to asparagine aa substitution (S139N) in the
prM protein of ZIKV resulted in a more infectious phenotype while a reverse mutation
(N139S) produced a less infectious virus (Yuan et al., 2017).

1.5.3 Envelope (E) protein
The envelope protein is the outermost covering of a ZIKV particle, 504 aa in
length and has a molecular weight of ~53 kDa (Dai et al., 2016). It has a single
glycosylation site at position 154 (N154) (Annamalai et al., 2017; Carbaugh et al., 2019;
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Routhu et al., 2019). Flaviviral E protein plays a significant role in recognition of host
cell receptor, membrane fusion, viral entry into the host cell and assembly of progeny
virions (Cruz-Oliveira et al., 2015; Valente and Moraes, 2019). It is cleaved by host
signal peptidase from the translated polyprotein in the ER lumen following which heterodimerization of E and prM occurs (Dai et al., 2016). The E protein consists of three major
domains: DI, DII, and DIII out of which EDIII is a major target for potent flavivirus typespecific neutralizing antibodies (mAb) (Beltramello et al., 2010; Dai et al., 2016). The
highly conserved fusion loop epitope (FLE) in DII is also a target for less potent crossneutralizing mAbs (Beltramello et al., 2010; Costin et al., 2013).

1.6 ZIKV: Nonstructural (NS) proteins
1.6.1 Non-structural protein 1 (NS1)
The non-structural protein 1 (NS1) of ZIKV is a 352 aa long glycoprotein. As
with most mosquito-borne flaviviruses, ZIKV NS1 has 2 conserved glycosylation sites
(Pryor and Wright, 1994). Depending on the glycosylation pattern, its molecular weight
ranges between 46 to 54 kDa (Muller and Young, 2013; Rastogi et al., 2016). Zika virus
NS1 protein shares structural similarity to related flaviviruses like DENV2 and WNV
(Muller and Young, 2013; Xu et al., 2016). NS1 exists in multiple locations in a cell. It is
found to be associated with intracellular vesicular compartments induced by virus
infection, on the surface of the infected cell and as a soluble lipoparticle that is secreted
(Muller and Young, 2013). Intracellular NS1 exists as a dimer and is associated with
vesicular compartments (Winkler et al., 1988). It functions as an essential cofactor in
virus replication and is found to co-localize with double-stranded RNA (dsRNA)
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(Mackenzie et al., 1996). The secreted form of NS1 forms a hexamer and is known to be
highly immunogenic. It has also been shown to interact with host factors and contributes
to disease pathogenesis (Avirutnan et al., 2006; Muller and Young, 2013). Studies with
several flaviviruses have suggested that NS1 protein glycosylation plays a critical role in
viral genome replication and pathogeneis (Annamalai et al., 2019; Pletnev et al., 1993;
Pryor et al., 1998; Pryor and Wright, 1994).

1.6.2 Non-structural protein 2 (NS2)
Proteolytic cleavage of ZIKV NS2 from the single polypeptide results in 2
proteins: NS2A and NS2B. While NS2A is 226 aa in length, NS2B is 130 aa long (Sirohi
and Kuhn, 2017). Following proteolytic cleavage, NS2A relocates to the endoplasmic
reticulum (ER) where it is an essential component of viral replication complex (Xie et al.,
2013). Additionally, it also helps in progeny virion assembly and downregulation of host
immune response (Xie et al., 2013). NS2B is a critical component of a so called ‘twocomponent protease’ and is essential to the proper functioning of the NS3 protein (Gupta
et al., 2015).

1.6.3 Non-structural protein 3 (NS3)
Flaviviral NS3 protein is one of the largest proteins and is ~617 aa in length
(Brecher et al., 2013). It has 2 domains: i) N-terminal serine protease (NS3Pro) domain,
and ii) C-terminal RNA helicase (NS3Hel) and triphosphatase (NS3RTPase) domain
(Brecher et al., 2013; Li et al., 1999; Warrener et al., 1993). It has been shown that the
association of NS2B with NS3 results in the proteolytic cleavage of NS3 and the
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formation of an active serine protease complex which serves a critical role in flavivirus
replication and progeny virion assembly (Arias et al., 1993; Chambers et al., 1991;
Chambers et al., 1993). The flaviviral NS2B-NS3 protease complex is highly conserved
and is a potential target for the development of inhibitors against flaviviruses (Li et al.,
2017b; Li et al., 2018).

1.6.4 Non-structural protein 4 (NS4)
Like NS2, flavivirus NS4 is processed to generate NS4A and NS4B, with an
additional highly hydrophobic 2K peptide that is located between them (Sirohi and Kuhn,
2017). NS4A is 127 aa long and is an important viral protein that remains associated with
cellular membranes and is involved in membrane rearrangements and the formation of
viral replication complexes (Miller et al., 2007; Roosendaal et al., 2006). Additionally, it
has also been demonstrated that ZIKV NS4A inhibits the interaction of RLR-MAVS and
impairs antiviral immune responses (Ma et al., 2018). NS4B is 251 aa in length and has
been shown to interfere with host type-I interferon response by blocking the activation of
STAT1 (Gerold et al., 2017; Munoz-Jordan et al., 2005). Both ZIKV NS4A and NS4B
have been shown to interfere with the Akt-mTOR axis of signaling and induce autophagy
in human neural stem cells (Liang et al., 2016). Addittionaly, inhibition of the AktmTOR axis, a key signaling pathway involved in neuronal development, along with the
activation of autophagy can be a potential mechanism by which ZIKV induces
microcephaly (Liang et al., 2016).

1.6.5 Non-structural protein 5 (NS5)
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Flaviviral NS5 is 903 aa in length and is the largest and the most conserved of all
the proteins (Song et al., 2021). It has two domains: i) a C-terminal RNA-dependent
RNA polymerase (RdRp) domain, and ii) a N-terminal methyltransferase (MTase)
domain (Elshahawi et al., 2019; Song et al., 2021). While the RdRp domain aides in de
novo viral RNA synthesis, the MTase domain contributes to methylation of the RNA cap
to form N-7-methyl-guanosine and 2’-O-methyl-adenosine using S-adenosyl-Lmethionine (SAM) as the methyl donor (Godoy et al., 2017; Zhang et al., 2017). In
addition to viral genome replication, NS5 also contributes to immune evasion. A recent
report demonstrated that ZIKV NS5 interacts with host retinoic acid-inducible gene I
(RIG-I) and prevents the nuclear translocation of interferon regulatory factor 3 (IRF3)
resulting in inhibition of interferon-β (IFN-β) production and signaling (Li et al., 2020).

1.7 Life cycle of ZIKV
ZIKV reservoir is maintained in mosquitoes and is transmitted to humans by
infected female Aedes mosquitoes while feeding for blood. Following this, the virus
interacts with several cell surface receptors like dendritic-cell-specific intercellular
adhesion molecule-3-grabbing non-integrin (DC-SIGN) (Pierson and Diamond, 2020;
Tassaneetrithep et al., 2003), Tyro3, Axl and Mertk (TAM) family of phosphatidylserine
receptors (Meertens et al., 2012; Perera-Lecoin et al., 2013) and/or T-cell
immunoglobulin domain and mucin domain (TIM) (Meertens et al., 2012; Pierson and
Diamond, 2020) and infects skin cells such as dermal epidermal keratinocytes,
fibroblasts, and immature dendritic cells (Hamel et al., 2015). The virus then infects
monocytes and macrophages in the draining lymph nodes leading to the spread of ZIKV
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Figure 1.4: Replication of ZIKV in host cells. The virus enters host cells by receptormediated endocytosis and fuses its membrane by an acidic-pH-triggered mechanism in
the endosome to release the viral RNA. The positive-stranded genomic RNA serves as
the only viral mRNA and leads to the synthesis of a polyprotein that is co- and post
translationally processed into three structural and seven nonstructural proteins. Virus
assembly takes place at the ER membrane and leads to the formation of immature virions,
which are further transported through the TGN that causes structural changes allowing
the cleavage of prM by the cellular protease, furin. The mature virions are transported to
the cell membrane and released by budding (Image sourced from Heinz et al, 2017).
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to other organs in the body such as the reproductive organs, the placenta, the brain and
spinal cord (Miner and Diamond, 2017).
Following interaction of the virus with cell surface receptor(s), clathrin-mediated
endocytosis internalizes the virion (Hackett and Cherry, 2018) and delivers to an early
endosome where the viral E protein undergoes structural modifications due to an acidic
environment (Perera-Lecoin et al., 2013). This is followed by the fusion of the endosomal
membrane with the viral envelope and release of the viral genomic RNA into the cytosol
(Pierson and Diamond, 2020) (Fig. 1.4).
Once inside a cell, ZIKV follows a similar chain of events as other members of
the Flaviviridae family. The genomic RNA serves as an mRNA template for cap
dependent translation which is initiated as soon as the genomic RNA is released into the
cytosol (Barrows et al., 2018). It encodes a single open reading frame that is flanked by a
5’ and 3’ UTR (Pierson and Diamond, 2020). The presence of the ER-localization signal
at the carboxy-terminal end of the C protein promotes its translocation to the ER
membrane where it rapidly associates with the ribosomes leading to co-translation and
insertion of the polyprotein into the ER lumen where the synthesis of nascent viral
proteins occurs. The nascent proteins are then cleaved by host and viral proteases to
generate the mature structural and non-structural proteins (Sager et al., 2018). The
flanking UTRs aide in translation of the viral RNA, replication, and subversion of host
immune response (Gebhard et al., 2011). The translation of viral proteins primes the host
environment for viral genomic RNA replication which occurs in endoplasmic reticulum
(ER) derived membrane-bound structures called replication compartments (RCs)
(Aktepe and Mackenzie, 2018; Barrows et al., 2018). The ultrastructure of such RCs has

16

been solved using cryo-EM tomography which shows spherical structures budding from
the cytosolic face of the ER and containing all the components necessary for viral RNA
replication and progeny virion assembly (Aktepe and Mackenzie, 2018; Pierson and
Diamond, 2020; Welsch et al., 2009). Apart from serving as the template for the synthesis
of viral proteins, the genomic RNA also serves as a template for RNA synthesis. The first
step involves the synthesis of a negative-sense RNA resulting in the formation of dsRNA
intermediate from which the positive-sense viral genome is produced (Lindenbach and
Rice, 2003). Along with the newly synthesized viral proteins, the positive-strand RNA is
packaged into progeny virus particles at the surface of the ER. These immature progeny
virions then bud from the ER surface and are transported into the TGN where the prM
protein is cleaved by furin-like proteases (Tomar et al., 2017; Wang et al., 2017). This is
followed by the homodimerization of the E protein resulting in mature virions which are
then released from the cell by exocytosis (Nambala et al., 2020) (Fig. 1.4).

1.8 ZIKV: Clinical Disease
In general, the clinical presentation of flavivirus infection in humans ranges from
mild illness that includes asymptomatic infection or episodes of self-limiting fevers to
severe and life-threating conditions including shock syndrome, haemorrhagic fever,
encephalitis, congenital defects, and hepatitis (Pierson and Diamond, 2020). While
majority of flavivirus, including ZIKV, infections do not present with any symptoms
(Musso et al., 2018; Musso and Gubler, 2016), a fraction of infected individuals may
present with symptoms including but not limited to conjunctivitis, myalgia, headache,
arthralgia and a rash that do not have any long-term consequences (Antoniou et al., 2020;
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Burger-Calderon et al., 2018; Pierson and Diamond, 2020). However, in 2015, the ZIKV
outbreak in Brazil caused major concern because of its association with microcephaly,
fetal growth retardation, brain malformations, and other neurological disorders,
collectively termed as congenital Zika syndrome (CZS) in infants and Guillain-Barré
syndrome in adults (Cao-Lormeau et al., 2016; Coyne and Lazear, 2016; Heukelbach et
al., 2016; Miner and Diamond, 2017; Rawal et al., 2016; Wheeler, 2018).
Microcephaly is a congenital abnormality in which the size of the head of the
fetus is smaller than the average head size of infants in the same age and sex group
(Antoniou et al., 2020) and such a condition is associated with reduced brain size and
developmental disabilities (Heukelbach et al., 2016) (Fig. 1.5). Microcephaly can occur
because of i) failure of the brain to grow appropriately during pregnancy due to reduced
neuron production, called congenital microcephaly, or ii) failure to develop post-partum
due to loss of dendritic connections, called secondary or postnatal microcephaly
(Barbelanne and Tsang, 2014; Faizan et al., 2016). The 2015 outbreak in Brazil saw an
increased incidence of infants born with congenital microcephaly where pregnant women
were diagnosed positive for ZIKV infection (Antoniou et al., 2020; Heukelbach et al.,
2016). Apart from that, ZIKV infection have also been associated, albeit infrequently,
with organ failures, subcutaneous bleeding and thrombocytopenia, encephalitis, and
meningitis (Carteaux et al., 2016; Karimi et al., 2016; Pierson and Diamond, 2018;
Swaminathan et al., 2016). Additionally, very few cases of death have been reported in
children with sickle cell anemia who were infected with ZIKV (Pierson and Diamond,
2018) and in adults with cancer (Pierson and Diamond, 2018; Swaminathan et al., 2016).
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Figure 1.5: Association of ZIKV infection and microcephaly. The circumference of
the head is compared between a healthy infant and an infant suffering from microcephaly.
Severe reduction in the size of the head along with developmental deficits is seen
newborn children suffering from congenital microcephaly. The 2015-16 ZIKV outbreak
in Brazil has been associated with an increased incidence of children born with
microcephaly (Image source: https://www.cdc.gov/pregnancy/zika/testing-followup/zika-syndrome-birth-defects.html).
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1.8.1 Association of ZIKV with microcephaly
The reemergence of ZIKV in 2015 as a potential pathogen that caused serious
developmental disorders redirected the scientific community to focus on investigating its
causal role in microcephaly. This was borne out of the observation that ZIKV was found
in the brain tissues of the fetuses suffering from microcephaly in women who, during the
first trimester of pregnancy, were infected with the virus (Driggers et al., 2016; Mlakar et
al., 2016). While, initially, it was unclear whether ZIKV targeted mature neurons or
progenitor cells that would eventually proliferate and differentiate into mature neurons,
several studies revealed that ZIKV directly targeted the cortical neural progenitor cells
leading to cell death (Li et al., 2016b; Tang et al., 2016). These findings provided
evidence for the Centers for Disease Control and Prevention (CDC) to declare that ZIKV
can cause microcephaly (Rasmussen et al., 2016). Additionally, the findings that not only
can ZIKV be transmitted via mosquitoes but can also be transmitted sexually between
individuals as well as vertically, from mother to the fetus, led to increased public
concerns (Christian et al., 2019; D'Ortenzio et al., 2016).
Although a direct understanding of the molecular mechanisms of ZIKV-induced
microcephaly is yet to be established, a number of reports have described several
probable mechanisms that may contribute to neurological deficits in developing brains.
One of the probable mechanisms is the accumulation of several nucleotide mutations in
key viral proteins that are involved in immune evasion (Mlakar et al., 2016). When
compared with the French Polynesian strain, the Brazilian strain contains three mutations
in the NS1 protein at sites K940E, T1027A, and M1143V which are implicated in
immune evasion (Mlakar et al., 2016; Wen et al., 2017). Additionally, a mutation in
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NS4B at T2509I, implicated in the inhibition of type I interferon signaling and in NS5 at
M2634V, implicated in the masking of the viral RNAs from recognition by the host, also
tend to contribute to the development of microcephaly (Mlakar et al., 2016). Another
report demonstrated that a single nucleotide mutation in the prM protein (S139N) lead to
increased virulence in mice and human neural progenitor cells (NPCs) and resulted in
more severe microcephaly and fetal demise in neonatal mice (Yuan et al., 2017).
Furthermore, the failure of host exonucleases to degrade subgenomic flaviviral RNAs
(sfRNAs) produced in the 3’ UTRs results in their accumulation in the cytosol and are
known to contribute to pathologic effects (Akiyama et al., 2016). Such observations can
explain the unprecedented emergence of ZIKV and its association with neurological
complications in the recent times.
Another potential mechanism for ZIKV-induced microcephaly can be attributed
to tissue tropism, i.e., the ability of the virus to infect specific types of cells and tissues.
ZIKV has been shown to preferentially infect neural progenitor cells and induce
apoptosis resulting in their depletion (Dang et al., 2016; Tang et al., 2016). Mature
neurons are also infected by the virus albeit to a lesser extent (Tang et al., 2016). This
phenomenon can very likely cause neurodevelopmental deficits. Indeed, when
developing wild type mice fetuses were infected with ZIKV by intra-ventricular
injections, differentiation of neural progenitor cells was significantly inhibited and this
resulted in the development of microcephaly (Li et al., 2016a). Additionally, with direct
intracranial inoculation of ZIKV in early post-natal wild-type mice pups depleted
proliferating cells in the stem cell compartment of the ventricular zone (Huang et al.,
2016).

21

While mouse models played a significant role in the initial studies needed to
establish the causal role of ZIKV for microcephaly, later studies in human brain organoid
cultures provided a much better understanding of the effect ZIKV infection in a more
relevant model system. Several groups have reprogrammed human pluripotent stem cells
(hPSCs) that can be induced and developed into three dimensional (3-D) organoids which
can be used as a more relevant model system to study specific aspects of brain
development and ZIKV pathogenesis (Lancaster et al., 2013; Qian et al., 2016). In
corroboration with the findings from mouse models, ZIKV infection of human
neurosphere organoid cultures in vitro was shown to induce cell death (Garcez et al.,
2016). Using such models, it has been shown that ZIKV infection induces pre-mature
differentiation of neural progenitor cells, leads to cell death, and can produce phenotypes
of microcephaly (Dang et al., 2016; Gabriel et al., 2017). ZIKV infection in the first
trimester of pregnancy has been shown to result in developmental deficits in the brain and
microcephaly in the fetus (Driggers et al., 2016; Mlakar et al., 2016; Olagnier et al.,
2016). Hofbauer cells (placental macrophages) and to a lesser extent, cytotrophoblasts, in
the placenta are the main targets of ZIKV and this leads to vertical transmission of ZIKV
from mother to the developing fetus (Quicke et al., 2016).
In addition to cell-autonomous effects of ZIKV infection on hNPCs, bystander
effect is also seen and may contribute to ZIKV induced pathogenesis (Christian et al.,
2019). In a 20-week old fetus with intra-uterine ZIKV infection, cell death by apoptosis
was seen in infected as well as uninfected bystander cortical neurons which was likely
due to neurotoxic factors including interleukin 1 β (IL1-β), and tumor necrosis factor α
(TNFα) secreted by the infected cells (Olmo et al., 2017). Additionally, glial cells and
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microglia (resident macrophages) act as viral reservoirs and also play a bystander role in
ZIKV induced disease. Microglia have been reported to be direct targets of ZIKV
infection as shown in the examination of brain tissue from aborted fetuses (Lum et al.,
2017). The proliferation of NPCs was found to be inhibited when they were grown in
conditioned media taken from infected primary microglia (Wang et al., 2018).
Furthermore, co-culturing of ZIKV-infected microglia and NPCs resulted in the spread of
infection to the NPCs resulting in cell death (Mesci et al., 2018). In human induced
pleuripotent stem cells (hiPSCs) derived populations, ZIKV successfully infected a
variety of cells like astrocytes, microglia-like cells and hNPCs but cell death by apoptosis
was only seen hNPCs (Muffat et al., 2018). Another study reported that infection of
human fetal neural stem cells (fNSCs) induces autophagy and subsequent cell death by
impairing the Akt/mTOR signaling cascade (Liang et al., 2016).

1.9 mTOR signaling cascade
Virus replication in host cells requires modulation of host cell pathways such as
energy metabolism and macromolecule synthesis as well as inhibiting antiviral responses
leading to production of viral progeny by the host cell machinery. The mechanistic
(formerly, called mammalian) target of rapamycin (mTOR) signaling cascade is critical
to the regulation of various cellular and metabolic processes including gene expression,
protein translation, cell proliferation, cell survival, autophagy, etc. (Foster and Fingar,
2010; Saxton and Sabatini, 2017b) (Fig. 1.6). The mTOR kinase is an evolutionarily
conserved serine/threonine kinase and exists as two functionally unique complexes,
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Figure 1.6: The mTOR cascade. Schematic showing the activation of mTORC1 leading
to protein synthesis, cell growth and proliferation and the inhibition of autophagy. The
phosphorylation of Akt at Ser 473 and Thr 308 by mTORC2 and PI3K activates it which
in turn phosphorylates and activates mTORC1. This leads to the phosphorylation of
P70S6K at Thr389, that regulates cell growth and cell cycle progression, and 4EBP1 at
multiple sites, that regulates the translation of mRNAs and cell proliferation. Activated
mTORC1 also phosphorylates ULK1 at Ser 757 resulting in the inhibition of ULK 1
function. Dephosphorylated ULK1 induces autophagy.
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mTOR complex (mTORC) 1 and mTORC2 (Foster and Fingar, 2010; Saxton and
Sabatini, 2017b). Each complex responds to different environmental stressors and has
unique regulatory properties, as well as cellular activities. The regulatory associated
protein of mTOR (Raptor) and the rapamycin insensitive companion of mTOR (Rictor)
are essential and distinguishing subunits of the mTORC1 and mTORC2, respectively and
act as scaffold proteins to assemble and stabilize respective complexes (Saxton and
Sabatini, 2017b; Yang et al., 2013). The phosphorylation and activation of downstream
effectors of mTORC1, the p70 ribosomal S6 kinase 1 (p70S6K), the eukaryotic initiation
factor 4E (eIF4E)-binding protein 1 (4EBP1), and Unc-51 like autophagy activating
kinase 1 (ULK1) regulate cap-dependent mRNA translation, metabolism, and
protein/organelle quality control mechanisms via autophagy (Saxton and Sabatini, 2017b;
Yang et al., 2013). In conditions of abundant nutrients, mTORC1 triggers ribosome
assembly and translation of mRNA leading to cellular growth and proliferation, and
inhibition of autophagy (Le Sage et al., 2016). On the other hand, the regulation of
mTORC2 is not fully understood, but is known to associate with the ribosomes and that
this association is triggered primarily by insulin-stimulated phosphatidylinositol 3-kinase
(PI3K) signaling (Zinzalla et al., 2011). mTORC2 phosphorylates several proteins of the
AGC family of kinases such as protein kinase C (PKC), protein kinase B (PKB/Akt), and
the serum and glucocorticoid induced kinases (SGK) regulating various aspects of
cytoskeletal structure modelling and cellular survival (Saxton and Sabatini, 2017b).

The mTOR cascade can be activated by multiple extracellular stressors that bind
to cell surface receptors which transduce the signal to PI3K (Le Sage et al., 2016). This
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results in the phosphorylation of the growth factor-activated kinase, Akt, at threonine308
(Thr308) and subsequently at serine 473 (Ser473) by mTORC2 resulting in its activation
(Le Sage et al., 2016; Sarbassov et al., 2005). An activated Akt phosphorylates tuberous
sclerosis protein 2 (TSC2) leading to the conversion of Rheb-GDP to Rheb-GTP resulting
in the activation of mTORC1 (Inoki et al., 2002; Menon et al., 2014) (Fig. 1.6). In
contrast, several intracellular and extracellular stimuli such as energy deficit, generation
of reactive oxygen species (ROS) and growth factor deficiency can inhibit the mTOR
cascade (Huang and Manning, 2009; Wang and Proud, 2011). Viruses including ZIKV
are also known to manipulate the mTOR signaling cascade to support their optimal
replication and pathogenic potential.

1.9.1 mTOR and microcephaly
mTOR signaling plays a very important role the proper development and
functioning of the brain and is key to phenomena such as neural stem cells proliferation,
spatio-temporal organization, migration and differentiation of neurons, assembly and
maintenance of neural circuits as well as regulation of complex behaviors such as
sleeping, feeding, and maintenance of circadian rhythms (Lipton and Sahin, 2014). The
mTOR signaling cascade is tightly regulated in proper brain development and any
abnormality or impairment has been implicated in several neurodegenerative diseases
(Lipton and Sahin, 2014). It has been observed that while early loss of mTOR function in
brain development leads to death and exhaustion of progenitor cells that are necessary for
proper brain development, over-activation may also be catastrophic and lead to rapid
exhaustion of stem cell niches resulting in serious pathological consequences (Lipton and
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Sahin, 2014). Studies done with a conditional mutant of mTOR demonstrated that while
early activation of the cascade induced microcephaly, delayed activation in post-mitotic
neurons lead to cortical hypertrophy, neuro-degeneration, and early death in mice (Kassai
et al., 2014). Attempts to dissect the roles of mTORC1 and mTORC2 by Rictor and
Raptor specific knockouts demonstrated that while Rictor knockouts that were specific to
the brain led to reduced neuronal size, shorter dendritic processes and smaller brains,
brain-specific Raptor knockouts resulted in reduced cell size and death, inhibition of
gliogenesis, and post-natal fetal demise (Cloetta et al., 2013; Thomanetz et al., 2013).

1.9.2 mTOR and autophagy
Apart from regulating cell proliferation, cellular metabolism, energy metabolism
and macromolecule synthesis, the mTOR signaling cascade also tightly regulates
autophagy, a cellular survival response that is known to sequester and degrade damaged
cell organelles, proteins and/or invading pathogens, by regulating the phosphorylation of
ULK1 at serine 757 (S757) (Khandia et al., 2019; Le Sage et al., 2016; Nazio et al., 2013;
Schmeisser and Parker, 2019). In the event of nutrient depletion, autophagy is activated
due to inactivation of mTORC1 and resulting dephosphorylation and activation of ULK1
(Schmeisser and Parker, 2019) (Fig. 1.6). In the context of virus replication, autophagy
can be pro-viral or anti-viral. Several viruses including coxsackievirus B3, hepatitis C
virus, coronaviruses and DENV are known to activate autophagy that enhances viral
protein synthesis and replication in infected cells (Ke, 2018; Ke and Chen, 2011; Lee et
al., 2008; Reggiori et al., 2010; Sir et al., 2008; Wong et al., 2008). Furthermore,
influenza A virus (IAV) has been shown to induce autophagosome formation at early
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time points of infection and at later time points inhibit the fusion of autophagosomes with
lysosomes thereby leading to accumulation of autophagosomes in the infected cells
(Gannage et al., 2009). In contrast, viruses like herpes simplex virus (HSV-1), human
immunodeficiency virus (HIV), and influenza virus subvert the activation of autophagy to
enhance their replication (Brand et al., 1997; Lu et al., 1995; Poppers et al., 2000).

1.10 Redox regulation and oxidative stress in virus infection
1.10.1 Nrf2 signaling cascade
Nuclear factor E2-related factor 2 (Nrf2) is a modular transcription factor that
belongs to the cap'n'collar family of transcription factors. It consists of a highly
conserved leucine-zipper (b-ZIP) structure and seven Neh (Neh 1-7) domains and is
known to counter oxidative stress (Ramezani et al., 2018; Tonelli et al., 2018). Normally,
Nrf2 remains associated with Kelch-like erythroid cell-derived protein with CNC
homology [ECH]-associated protein 1 (Keap1) in the cytoplasm which drives its
interaction with cullin-3-based E3ubiquitin ligase (Cul3) (Itoh et al., 1999; Kobayashi et
al., 2004). This association results in poly-ubiquitination of Nrf2, and subsequent
proteasome mediated degradation resulting in very low basal levels of Nrf2 in cells (Itoh
et al., 1999; Kobayashi et al., 2004; Taguchi et al., 2011; Tonelli et al., 2018). When a
cell undergoes oxidative stress, an imbalance in the generation and neutralization of
reactive oxygen species (ROS) occurs and the association of Keap1 with Nrf2 is impaired
leading to free Nrf2 which then translocates to the nucleus and induces the expression of
antioxidant response elements (AREs) (Baird et al., 2014; Itoh et al., 1997; Ramezani et
al., 2018). AREs are a cluster of multiple genes associated with antioxidant defense, ROS
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detoxification enzymes, NADPH regeneration and regulation of metabolism that protect
the cell from the damaging effects of ROS (Baird et al., 2014; Hayes and DinkovaKostova, 2014; Ramezani et al., 2018). The restoration of redox balance is sensed by
Keap1 which translocates into the nucleus and binds to Nrf2, thereby dissociating Nrf2
from the AREs. The Keap1/Nrf2 complex translocates back to the cytoplasm where Nrf2
is poly-ubiquitinated and degraded (Ramezani et al., 2018; Sun et al., 2007).

1.10.2 Nrf2 regulates cellular antioxidant defense system and pentose phosphate
pathway (PPP)
Generally, ROS are formed as a byproduct of normal cellular metabolism by
various cellular enzymes in the mitochondria, endoplasmic reticulum (ER) and
peroxisomes and are needed to maintain cellular homeostasis and serve as critical
components of cellular signaling (Arfin et al., 2021; Halliwell, 2007). Cellular
antioxidant system plays an important role in maintaining a balance between the
production and scavenging of ROS thereby protecting the cell against damage and
subsequent death (Dandekar et al., 2015; Pizzino et al., 2017). Oxidative stress is a
condition in which the generation and scavenging of the ROS is impaired and the balance
shifts more towards the generation (Sies, 2015; Zhang et al., 2019). Studies done in
flaviviruses have demonstrated that viruses such as DENV, JEV, and HCV. induce
glucose uptake, increase expression of key glycolytic and PPP enzymes, enhance lipid
biosynthesis as well as induce unfolded protein response (UPR) and oxidative stress in
infected cells (Fontaine et al., 2015; Zhang et al., 2019). The oxidative stress induced by
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the infection of flaviviruses has been implicated in the virus-induced pathogenesis
(Valadao et al., 2016).
DENV infection has been shown to alter intracellular GSH levels, induce
oxidative stress and cell death in infected cells (Seet et al., 2009; Tian et al., 2010; Wang
et al., 2013). Recent studies have revealed that in DENV-infected cells, the viral NS2B3
complex interacts physically with and induces degradation of Nrf2 in a proteolysisindependent manner, likely through lysosomal degradation/autophagy (Ferrari et al.,
2020; Zevini et al., 2020). Degradation of Nrf2 leads to suppression of antioxidant
response genes resulting in ROS-associated inflammatory responses and cell death
(Ferrari et al., 2020; Zevini et al., 2020). Glutathione (GSH) is key player in the
antioxidant defense system of a cell and Nrf2 is known to control the critical components
of the GSH antioxidant system (Tonelli et al., 2018). The regulation of GSH levels by
Nrf2 in a cell is directly controlled by the expression of the glutamate-cysteine ligase
(GCL) complex that consists of two subunits: the catalytic subunit (GCLC) and the
modifier subunit (GCLM) (Moinova and Mulcahy, 1999; Wild et al., 1999).
In addition to regulating the levels of GSH, Nrf2 also regulates the expression of
enzymes that are key to the conversion of nicotinamide adenine dinucleotide phosphate
(NADP) to its reduced form NADPH, thereby playing an essential role in maintaining
cellular redox homeostasis (Gorrini et al., 2013; Tonelli et al., 2018). NADPH is central
to providing reducing power for the majority of ROS-detoxifying enzymes (FernandezMarcos and Nobrega-Pereira, 2016). Nrf2 induces the production of NADPH by
positively regulating principal NADPH-generating enzymes glucose-6-phosphate
dehydrogenase (G6PD), and 6-phosphogluconatedehydrogenase (6PGD), key enzymes
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involved in the oxidative branch of the pentose phosphate pathway (PPP) as well as other
enzymes like malic enzyme 1 (ME1) and isocitrate dehydrogenase 1 (IDH1) (DeBlasi
and DeNicola, 2020; Lee et al., 2003; Mitsuishi et al., 2012; Wu et al., 2011). The PPP
branches out from the glycolysis pathway and serves two major functions: i) generation
of ribose-5-phosphate from glucose-6-phosphate for the synthesis of nucleotides and ii)
generation of NADPH that is used by the cellular oxidative defense mechanism (Patra
and Hay, 2014). Both of the above mentioned processes are carried out by the oxidative
part of PPP (Patra and Hay, 2014). Under oxidative stress condition, the non-oxidative
part of PPP utilizes transketolase and transaldolase enzymes to convert ribose-5phosphate into glucose-6-phosphate that can feed into the oxidative part of PPP to
generate more NADPH while also being shunted into glycolysis (Patra and Hay, 2014).

1.11 Modulation of cellular metabolism by virus infection
Virus infection modulates and reprograms cellular metabolism to aid in
replication and optimal viral progeny production (Thaker et al., 2019a). Metabolic
changes in virus infected cells closely resemble cancer cells and are characterized by
increased glycolytic metabolism and anabolic processes to enhance synthesis of
macromolecules such as nucleotides and lipids (Delgado et al., 2012; Pavlova and
Thompson, 2016; Thaker et al., 2019a). Several metabolic profiling studies show that
infection of host cells with viruses such as adenovirus, human cytomegalovirus (hCMV)
and influenza A virus lead to a significant increase in the rate of glycolysis of the host
cells (Thaker et al., 2019a). Furthermore, the infection of cells with adenovirus leads to
increased glutaminolysis, the process in which glutamine is metabolized to glutamate and
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aspartate resulting in the production of pyruvate, lactate, and citrate (Thai et al., 2015).
Infection with hCMV has also been reported to increase the translocation of glucose
transporter, GLUT 4, to the cell surface and increase glucose uptake by the infected cells
(Yu et al., 2011). Infection with prototypic flaviviruses like DENV and ZIKV have also
been shown to enhance glycolysis and fatty acid biosynthesis in infected cells (Fontaine
et al., 2015; Thaker et al., 2019b)

1.12 Overall hypothesis and objectives
Determining the effect of ZIKV infection on critical host cell signaling pathways
like the mTOR cascade is essential to achieve a holistic understanding of the molecular
basis of ZIKV induced pathogenesis. Additionally, a detailed understanding of ZIKV
induced modulations of host cell pathways can aid in the development of antiviral
strategies that target the host cell. The association of ZIKV infection with increased
incidence of microcephaly in neonates together with the findings that both inhibition and
hyperactivation of the mTOR signaling cascade can lead to defective brain development
and death of neural progenitor cells led me to hypothesize that ZIKV infection and
pathogenesis involves the dysregulation of the mTOR signaling pathway. Host
metabolic adaptations are required for viral replication. We hypothesize that ZIKV virus
infection hijacks the host cell metabolic machinery for optimal virus propagation, and
this might lead to increased rate of glucose metabolism and oxidative stress. These
hypotheses formed the basis to investigate the role of cellular processes such as the
mTOR signaling pathway, cell metabolism and antioxidant response in ZIKV replication.
The following objectives were addressed in this dissertation:
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1.12.1 Do mTOR signaling cascade and autophagy regulate ZIKV infection?
The experimental approach and the results of the studies in this objective are
described in chapter 3.
1.12.2 How does host antioxidant defense regulate ZIKV replication?
The experimental approach and the results of the studies in this objective are
described in chapter 4.
1.12.3 Does ZIKV infection depend on cellular glycolysis and gluconeogenesis?
The experimental approach and the results of the studies in this objective are
described in chapter 5.
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CHAPTER 2: MATERIALS AND METHODS

2.1 Cell culture
The Lund Human Mesencephalic (LUHMES) cells (ATCC CRL-2927), a
subclone of tetracycline-controlled, v-myc-overexpressing human mesencephalic-derived
cell line, MESC2.10 (Scholz et al, 2011), obtained from the American Type Culture
Collection Biosource Center, were cultured as described previously (Scholz et al., 2011).
Briefly, cell culture flasks and dishes were pre-coated overnight with 50 µg/ml poly-Lornithine (Sigma-Aldrich, Cat. # P2533-10G) followed by washing with sterile distilled
water. Subsequently, they were coated with 1 µg/ml fibronectin (BD Biosciences, Cat. #
354008), washed with sterile water, air-dried, and stored at 4⁰ C before use. The cells
were cultured in Dulbecco’s Modified Eagle’s Medium/F12 (DMEM/F12, Hyclone, Cat.
# SH30023.02), supplemented with Neuroplex N-2 (Gemini, Cat. # 400-163), 2 mM Lglutamine (Hyclone, Cat. # SH3003401) and 40 ng/ml recombinant basic fibroblast
growth factor, (Peprotech, Cat. #100-18C). A172 cells (Glioblastoma, Homo sapiens,
ATCC CRL-1620) were grown in DMEM supplemented with 10% heat inactivated fetal
bovine serum (FBS) and 1x antibiotics solution (100 U/ml penicillin, 20 U/ml
streptomycin, PS). The human neuroblastoma SK-N-SH (Neuroblastoma, Homo sapiens)
cells stably expressing EGFP-LC3 (Garcia-Garcia et al, 2013) were grown in DMEM
containing 10% FBS and PS. Vero E6 (Epithelial, Cercopithecus aethiops, ATCC CRL1586) cells were grown in DMEM supplemented with 10% FBS and PS. All cells were
maintained at 37°C, 5% CO2 atmosphere in a humidified incubator.
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2.2 Preparation and concentration of recombinant ZIKV (rMR) stock
Stocks of the infectious clone-derived MR766 ZIKV (rMR) were prepared in Vero
cells as described previously (Annamalai et al, 2017). Briefly, Vero cells were infected
with rMR virus at a multiplicity of infection (MOI) of 0.1 plaque forming unit per cell
(PFU/cell). The virus was allowed to adsorp at 37⁰ C for 1 hr following which the
inoculum was removed and virus growth medium (VGM) [DMEM containing 2%FBS,
PS, 20 mM hydroxyethyl piperazine ethane sulfonic acid (HEPES), 1 mM sodium
pyruvate, and non-essential amino acids] was added to the cells. The infected cells were
incubated at 37⁰ C for 4-5 days until cytopathic effect (CPE) was evident. The culture
supernatant was collected and clarified at 10,000xg for 30 mins at 4⁰ C. Following
clarification, the stock virus was stored in small aliquots at -80⁰C. In some experiments
where higher MOI was used, high titer virus stocks were prepared by ultracentrifugation.
Briefly, ~10 ml of clarified culture media containing the virus was taken in an
ultracentrifuge tube and underlaid with ~2 ml of 20% sucrose in PBS. This was followed
by centrifugation at 100,000xg for 4 h at 4⁰C. The virus pellet was resuspended in 200 µl
of PBS and stored at -80⁰C.

2.3 Plaque assay
Plaque assay for virus quantification was done as described in Annamalai et al,
2017. Briefly, Vero E6 cells were plated in 12 well plate 24 hr prior to the assay. The
required monolayer confluency was 90-100%. Ten-fold serial dilutions of virus stock or
culture supernatants for titration were made in cold VGM. One hundred microliters of
each dilution of the virus were plated in duplicates onto Vero E6 cell monolayers. Cells
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were incubated at 37°C for 1 h with intermittent rocking every 10 min intervals to
prevent the cell monolayer from drying and to ensure uniform exposure of the virus
suspension to the cell monolayer. Following virus adsorption, the inoculum was removed,
and the cell monolayer was washed once with phosphate buffered saline (PBS) to remove
any unbound virus. A 1:1 mixture of 2% low gelling temperature (LGT) agarose
dissolved in sterile distilled water and 2X VGM was added to the cells. The overlay was
allowed to solidify for 15 min at room temperature and the cells were incubated for 5
days at 37°C in a humidified cell culture incubator for plaques to develop. Following
incubation, the cells were fixed with fixing solution containing 10% formaldehyde in
PBS for at least 60 min. The agarose plugs were removed, and the cell monolayers were
stained for 30 minutes with staining solution containing 0.1% crystal violet and 30%
methanol in PBS. The staining solution was removed, and the cells were washed with
distilled water. The number of plaques was manually counted for each dilution and the
titer of the virus in the supernatant was determined by multiplying the average number of
plaques with the dilution factor and was expressed as plaque forming units per ml
(PFU/ml).

2.4 Antibodies and other reagents
Anti-phosphorylated (p)-p70S6K (T389)/(p)-p85S6K (T412) (Cat. # 9234S), antip70S6K (Cat. # 2708S), anti-p-Akt (S473) (Cat #. 9018B), anti-Akt (Cat. # 2938P), antimTOR (Cat. # 2983), anti-Rictor (Cat. #2114), anti-Raptor (Cat #2280), and anti-Nrf2
(Cat #12721T) antibodies were obtained from Cell Signaling Technologies. Anti-p62
(Cat. # ab109012), anti-G6PD (Cat # ab993), and anti-6PDG (Cat. # 129199) were
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obtained from Abcam. Anti-ZIKV E antibody was obtained from Genetex (Cat. #
GTX1333325). Anti-flavivirus group antigen antibody was obtained from Millipore
(4G2, Cat # MAB10216-I-100UG). Anti-β-actin (Cat. # A2228), goat anti-rabbit
immunoglobulin (IgG)-horseradish peroxidase (HRP)-conjugated (Cat. # A6154), and
goat anti-mouse IgG–HRP conjugated (Cat. # A4416) antibodies were obtained from
Sigma-Aldrich. Choloroquin (CQ) (Cat. # C6628) was obtained from Sigma-Aldrich and
dissolved in water. 3-Methyladenine (3-MA) was obtained from Tokyo Chemical
Industry (Cat. # M2518) and was prepared fresh by dissolving in warm water (37-50oC)
prior to treating cells. Rapamycin was obtained from LC Laboratories (Cat. # R-5000)
and dissolved in dimethyl sulfoxide (DMSO). Torin1 was obtained from Apex Bio (Cat.
# A8312-5) and dissolved in ethanol. MRT68921 (Cat. # S7949) were obtained from
Selleck Chemical and dissolved in water. 6-aminonicotinamide (6-AN) (Cat #
AAL0669203) was obtained from Thermo Fisher Scientific and dissolved in DMSO. Nacetyl L-cysteine (NAC) (Cat # AC160280250), Ascorbic acid (Cat # AC352680050),
and 2-Deoxy-D-glucose (2DG) (Cat # AC111980050) were obtained from Acros
Organics and dissolved in water. Etomoxir (sodium salt) (Cat # 11969) was obtained
from Caymen Chemical and dissolved in water. Buthionine sulfoximine (BSO) was
obtained from Caymen Chemical (Cat # 14484) and dissolved in water. BPTES (Cat #
19284), UK5099 (UK) (Cat # 16980) and Rotenone (Cat # 13995) were obtained from
Caymen Chemical and were dissolved in DMSO.
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2.5 Immunofluorescence
For detection of ZIKV E protein in infected cells, cells were mock-infected or
infected with ZIKV at indicated MOIs. After 24 h, cells were washed with cold 1X PBS
and fixed with 1:1 mixture of methanol and acetone at -20⁰C for 10 mins. The fixed cells
were washed with PBS and stained with 4G2 (anti-flavivirus group) antibody (1:1000 in
PBS). After incubation for 1 h on a shaking platform, excess unbound antibody was
washed with PBS. The cells were stained with Alexa 488 conjugated anti-mouse IgG
secondary antibody (1:1000 in PBS) for 1 h. Following washing of unbound antibody
with PBS, images were acquired using a Nikon Eclipse Ts2R fluorescence microscope.

2.6 Pharmacological inhibition
For pharmacological inhibition of mTOR kinase, cells were either left untreated
or were pre-treated with 250 nM torin1 or 1 µM rapamycin for 1 h prior to being mockinfected or infected with ZIKV at a MOI of 1 with or without the inhibitors and incubated
in media with or without the inhibitors. Similarly, for inhibition of autophagy, cells were
either left untreated or treated with 3-MA (5 mM) or MRT68921 (1 µM) for 1 h prior to
infection with ZIKV with or without the inhibitors and further incubated in media with or
without the inhibitors till the indicated time points. For the inhibition of autophagic flux,
cells were treated with CQ (50 µM) 4 h prior to the termination of the experiment. For
inhibition of de novo synthesis of GSH, cells were incubated with culture medium
without or with BSO (500 µM) following virus adsorption, for 48 hpi. Similarly, PPP
inhibition was achieved by treating cells with 6-AN following virus adsorption, for 48
hpi. For inhibition of glycolysis, following infection with ZIKV, cells were either left
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untreated or were treated with 2DG (10 mM) for the indicated time points post infection.
For virus yield under conditions of various drug treatments, 100 µl of culture supernatant
was collected at the indicated hours post-infection (hpi) and infectious virus titers were
determined by plaque assay as mentioned above.

2.7 siRNA-mediated protein depletion
For the depletion of endogenous mTOR, Rictor, Raptor, Nrf2, G6PD and 6PDG
proteins in A172 cells, we used human small interfering RNA (siRNA) pools targeting
mTOR (Cat. # J-003008-11 and J-003008-12), Rictor (Cat. # J-016984-05 and J-01698406), Raptor (Cat. # J-004107-05 and J-004107-06), Nrf2 (Cat. # L-003755-00-0005),
G6PD (Cat. # L-008181-02-005) or 6PDG (Cat. # L-008371-00-005) obtained from
Dharmacon Inc. The siRNAs (obtained at 5 nmol amounts) were reconstituted in
nuclease-free water. Cells were transfected with siRNAs at a final concentration of 80
nM for mTOR, Rictor and Raptor or 100 nM for Nrf2, G6PD and 6PDG using
Lipofectamine RNAiMax (Invitrogen, Cat. # 13778030) following manufacturer’s
recommendation. Briefly, 80 or 100 nM siRNA and Lipofectamine RNAiMax were
incubated in OptiMEM medium to facilitate RNA liposome complex formation for 15
mins at room temperature (RT). A non-targeting (NT) siRNA (Qiagen, Cat. # 1027281)
at 100 nM was used as negative control. These concentrations of siRNAs were found to
be nontoxic to the cells and cell viability was estimated to be over 90% during the
treatment. At 24 hours post siRNA transfection (hpt), the cells were replenished with
DMEM containing 2% FBS and 1X antibiotics and were incubated for further 24-48 h
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prior to virus infection. The extent of protein depletion was determined by western
blotting as mentioned below using corresponding antibodies.

2.8 Preparation of cell lysates, SDS-PAGE and Western blotting
For western blotting, cell monolayers were washed once with cold PBS, detached
with trypsin (Gibco Cat #25200056) and collected in microcentrifuge tubes. This was
followed by centrifugation at 500xg for 5 min at 4oC. The cell pellet was resuspended in
RIPA lysis buffer (25 mM Tris-HCl, pH 7.6, 150 mM NaCl, 1 % Triton X-100, 1 %
sodium deoxycholate, 0.1 % SDS) supplemented with the Halt Protease and Phosphatase
inhibitor cocktail (ThermoFisher, Cat. # 1861281) and incubated on ice for 5 min and
frozen at -80⁰ C for 1 hr. This was followed by thawing the cells on ice and sonicating at
10% amplitude for 5-10 secs, 3 times. The cell lysates were clarified by centrifugation at
10,000xg for 5 min and total protein quantification was done using the bicinchoninic acid
(BCA) assay kit (Pierce, Cat. # 23225). Twenty five µg of total protein was separated by
electrophoresis on 6 % or 8 % polyacrylamide gel containing sodium dodecylsulphate
(SDS-PAGE). The separated proteins were transferred onto polyvinylidene difluoride
(PVDF) membranes (ThermoFisher, Cat # 88520) using a Bio-Rad semi-dry transfer
system. Non-specific protein binding was blocked with 5% non-fat milk or with bovine
serum albumin (for phosphorylated proteins) in Tris-buffered saline containing 0.2 %
tween-20 (TBS-T) for 1 hr followed by incubation with the appropriate primary
antibodies (dilution: 1:5000 for β-actin and 1:1000 for all others) at 4°C overnight.
Membranes were washed three times with TBS-T and followed by incubation with goat
anti-rabbit or goat anti-mouse HRP-conjugated secondary antibodies (dilution: 1:5000) at
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room temperature (RT) for 2 h. The blots were washed three times with TBS-T and bands
were detected using ECL western blotting substrate (Pierce, Cat. # 32106) in a BioRad
imager. Protein bands were analyzed by ImageJ software (NIH).

2.9 Fluorescence activated cell sorting
A172 cells were seeded in 12-well plates at a density of 20,000 cells per well.
They were left untreated or treated with pharmacological inhibitors, mock-infected or
infected with ZIKV and incubated for 96 hrs. Culture media were collected and the cell
monolayers were washed with PBS, detached with trypsin, resuspended with collected
medium, and pelleted at 500xg for 10 mins. The cell pellet was re-suspended in staining
solution containing propidium iodide (PI, 1 µg/ml, Sigma/Aldrich, Cat # P4170) for
detecting loss of plasma membrane integrity and, monochlorobimane (mBCl, 10 μM,
Molecular Probes, Cat # M1381MP) in PBS to determine intracellular glutathione (GSH)
content and incubated at room temperature (RT) until analysis. Cell viability was
determined by flow cytometry (Fluorescence Activated Cell Sorting, FACS) using CytekDxP-10 (BD Biosciences). PI was detected using BluYel FL-3 (488 nm excitation,
695/40 nm emission) and mBCl was detected using VioFL1 (389 nm excitation and 483
nm emission) channels. At least 10,000 events were recorded per sample. Viable cells
were gated as mBCl positive (+) and PI negative (−). The data analysis was done in
FlowJo 7.6.5 software.
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2.10 Confocal microscopy
SK-N-SH cells stably expressing EGFP-LC3 (Garcia-Garcia et al., 2013) were
seeded in 35mm glass bottom cell culture dishes at a density of 200,000 cells per dish.
After 24 hrs of seeding, the cells were mock-infected or infected with ZIKV at an MOI of
1 and incubated for 48 hrs. Four hours prior to the termination of the experiment, the cells
were exposed to CQ (50 M). To visualize lysosomes, cells were incubated with 1 µM
LysoTracker Red DND-99 (Invitrogen, Cat. # L7528) for 10 min, the monolayer was
washed once with PBS and immediately imaged as described (Garcia-Garcia et al.,
2013). Fluorescent imaging was done at the microscopy core facility of University of
Nebraska-Lincoln using a Nikon A1R-Ti2 confocal system. Images were acquired using
NIS-Elements software (Nikon). EGFP-LC3 puncta in cells were counted from three
representative fields of images and were analyzed statistically.

2.11 Statistical analysis
Experimental replicas were independent and performed on separate days. The
data were analyzed by using one-way or two-way ANOVA, and the appropriate post-hoc
test using Graphpad Prism package. When ANOVA assumptions were not met (normality
[Shapiro–Wilk test] or equal variance [Kruskal-Wallis]), one-way ANOVA on Ranks or
data transformation (two-way ANOVA) were performed on the data collected. Data were
plotted as mean ± standard error of mean (SEM) using the same package for statistical
analysis.
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CHAPTER 3: mTOR SIGNALING ACTIVATION ANTAGONIZES
AUTOPHAGY TO FACILITATE ZIKA VIRUS REPLICATION

Part of the studies described in this chapter was published in the Journal of Virology,
2020. Bikash R. Sahoo, Aryamav Pattnaik, Arun S. Annamalai, Rodrigo Franco, Asit K.
Pattnaik 2020. Mechanistic Target of Rapamycin Signaling Activation Antagonizes
Autophagy to Facilitate Zika Virus Replication. Journal of Virology, 94: e01575-20.
doi:10.1128/JVI.01575-20.
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3.1. Abstract
ZIKV is a flavivirus and is transmitted by mosquitoes of the Aedes species. While
most infections do not produce any clinical symptoms, the recent outbreak in Brazil has
been linked to microcephaly and other neurological defects in neonates and GuillainBarré syndrome in adults. The molecular mechanisms regulating ZIKV infection, and the
pathogenic outcomes associated with it are not completely understood. Signaling by the
mechanistic (mammalian) target of rapamycin (mTOR) kinase is important for cell
survival and proliferation. Several previous studies across multiple virus families have
demonstrated that virus infections hijack this critical cellular signaling cascade for their
replication. In this study, we show that in human neuronal precursor cells and glial cells
in culture, ZIKV infection activates both mTOR complex 1 (mTORC1) and mTORC2.
When mTOR kinase was inhibited either by Torin1 or rapamycin, significant reduction in
ZIKV protein expression and progeny production was observed. Depletion of the
defining subunit of mTORC1, Raptor, in glial cells by small interfering RNA (siRNA)
resulted in inhibition of ZIKV protein expression and viral replication. The depletion of
Rictor, the unique subunit of mTORC2, or the mTOR kinase in the cells also inhibited
the viral processes, albeit to a lesser extent. ZIKV infection in glial cells was seen to
transiently induce autophagy at early time point post-infection. It was seen that when
autophagosome elongation is impaired by the class III phosphatidylinositol 3-kinase
(PI3K) inhibitor 3-methyladenine (3-MA), viral protein accumulation and progeny
production was enhanced. Furthermore, the phosphorylation at S757 and the resulting
inactivation of ULK1 by mTOR at later stages of ZIKV infection suggests a link between
autophagy inhibition and mTOR activation by ZIKV. Accordingly, inhibition of ULK1
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(by MRT68921) or autophagy (by 3-MA) reversed the effects of mTOR inhibition,
leading to increased levels of ZIKV protein expression and viral progeny production.
These results demonstrate that ZIKV replication requires the activation of both mTORC1
and mTORC2, which negatively regulates autophagy and facilitates the viral replication.
Additionally, these findings provide a potential mechanism of the neurological diseases
induced by ZIKV infection.

3.2. Introduction
Recent studies suggest that ZIKV infection leads to defective neuronal cell
development and death of neuronal precursor cells and that such events might lead to the
development of neurological complications (Faizan et al., 2016). The mTOR signaling
cascade is a key pathway that regulates cellular growth, proliferation, and survival
(Saxton and Sabatini, 2017b). mTOR is a serine/threonine kinase that belongs to the
phosphatidylinositol 3-kinase (PI3K)-related protein kinase family and constitutes the
catalytic subunit of two functionally distinct complexes, mTOR complex 1 (mTORC1)
and mTORC2 (Saxton and Sabatini, 2017b). The regulatory associated protein of mTOR
(Raptor) and the rapamycin-insensitive companion of mTOR (Rictor) are essential and
distinguishing subunits of mTORC1 and mTORC2, respectively (Saxton and Sabatini,
2017b) and act as scaffold proteins to help assemble and stabilize the respective
complexes (Yang et al., 2013). Phosphorylation and subsequent activation of downstream
effectors of mTORC1, such as the p70 ribosomal S6 kinase 1 (p70S6K), the eukaryotic
initiation factor 4E (eIF4E)-binding protein 1 (4EBP1), and Unc-51-like autophagy
activating kinase 1 (ULK1), regulate cap-dependent mRNA translation, metabolism, and
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protein/ organelle quality control mechanisms (Saxton and Sabatini, 2017b). mTORC2 is
reported to phosphorylate several proteins of the AGC family of kinases, such as protein
kinase C (PKC), protein kinase B (PKB/Akt), and the serum and glucocorticoid induced
kinases (SGK) and this regulates various aspects of cytoskeletal structure modeling and
cellular survival (Saxton and Sabatini, 2017b).
mTOR signaling is one of the critical pathways that is essential for proper brain
development and is also known to regulate autophagy (Ganley et al., 2009). Virus
infection is known to alter the mTOR complex activity (Buchkovich et al., 2008; Jan et
al., 2016; Le Sage et al., 2016). While poxviruses disrupt mTORCs’ regulatory cascade
(Meade et al., 2018), adenoviruses are known to activate mTORC1 (de Groot et al., 1995;
O'Shea et al., 2005). The NS1 protein of influenza A virus activates mTOR signaling
network by phosphorylating and activating Akt, a key protein in the mTOR signaling
pathway, and by inhibiting REDD1 (regulated in development and DNA damage
responses 1), a key inhibitor of mTORC1 (Kuss-Duerkop et al., 2017). Flaviviruses such
as west Nile virus (WNV) and dengue virus (DENV) have been reported to activate
PI3K/Akt and mTORC signaling (Lee et al., 2005; Shives et al., 2014) that results in
increased viral protein expression and replication (Shives et al., 2014). The NS4A and
NS4B proteins of ZIKV have been shown to inhibit Akt-mTOR signaling in human fetal
neuronal stem cells (Liang et al., 2016).
Autophagy is a cellular homeostatic process involving the formation of
autophagosomes, which engulf protein aggregates, damaged cell organelles, and
intracellular pathogens marked for degradation (Deretic et al., 2013) and is known to play
a major role in eliciting a host response against virus infections (Lee and Iwasaki, 2008).
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Pathogens like herpes simplex virus 1 (HSV-1) (Poppers et al., 2000)(29), human
immunodeficiency virus (HIV) (Brand et al., 1997), and influenza virus (Lu et al., 1995)
are known to inhibit the activation of autophagy to enhance virus replication. While
induction of autophagy facilitates DENV replication (Chu et al., 2014), it restricts WNV
replication and protein synthesis and acts as an antiviral response of the host cell
(Kobayashi et al., 2014). In contrast, ZIKV infection has been shown to induce
autophagy human fetal neural stem cells and this inhibits neurogenesis (Liang et al.,
2016). Since mTOR and autophagy are key signaling cascades that regulate many cellular
processes, exploring how ZIKV perturbs these pathways is important to gain better
insights into the processes of ZIKV infection, and pathogenesis.
In this chapter, we demonstrate that ZIKV infection results in the activation of
both mTORC1 and mTORC2 in neuronal and glial cells. Inhibition of mTOR kinase
reduces ZIKV protein expression and progeny virus production. Additionally, these
studies reveal that ZIKV infection induces autophagy at early stages of infection but that
later in infection, autophagy is subdued by the concerted activation of both mTORC1 and
mTORC2 that leads to viral protein accumulation in the infected cells and virus growth.
These results demonstrate that activation of mTOR signaling, and the subsequent
suppression of autophagy are events that are required for ZIKV growth in vitro and
provide a framework for further research on the role of these two cellular pathways for
understanding of the mechanism(s) underlying ZIKV induced pathogenesis.

3.3. Results
3.3.1. ZIKV infection activates mTORC1 and mTORC2 in neuronal and glial cells
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in culture.
Virus infections are known to modulate mTOR signaling (Buchkovich et al., 2008;
Jan et al., 2016; Le Sage et al., 2016). In order to investigate the effect of ZIKV infection
on mTOR signaling in neuronal cells, we used neuronal progenitor LUHMES cells
(Scholz et al., 2011) and examined the status of mTORC1 activation in these cells
infected with ZIKV by determining the levels of phosphorylation (p) of eukaryotic
translation initiation factor 4E binding protein (4E-BP1), a downstream substrate of
mTORC1 (Saxton and Sabatini, 2017b). 4E-BP1 is phosphorylated at multiple sites
resulting in its inhibition and dissociation from eIF4E which leads to cap-dependent
protein translation in cells (Gingras et al., 1999; Gingras et al., 1998). Using an antibody
that detects the phosphorylation of 4E-BP1 at residues Thr37 and Thr46 (residues
phosphorylated by mTORC1), we observed that upon ZIKV infection, there was an
increase in the levels of phosphorylated protein with time, clearly indicating the
activation of mTORC1 (Fig. 3.1A). Additionally, we also sought to determine the levels
of p-p70S6K, another downstream substrate of mTORC1 (Saxton and Sabatini, 2017b;
Yang et al., 2013). Western blot analysis showed that the levels of p-p70S6K at threonine
389 (T389) increased following ZIKV infection (Fig. 3.1B). In the LUHMES cells, the
phospho-specific antibody used also detected a second phosphorylated isoform of the
protein, p-p85S6K (T412), which is derived from the same gene and contains 23 extra
amino acids at the amino terminus (Pullen and Thomas, 1997). The increase in
phosphorylation of both the downstream substrates of mTORC1 was evident at 12 to 24 h
post-infection (hpi) and continued to increase until 48 hpi compared to the mock-infected
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Figure 3.1: ZIKV infection activates both mTORC1 and mTORC2 in neuronal and
glial cells in culture. LUHMES cells were either mock-infected (M) or infected with
ZIKV at an MOI of 1 and cells lysates were prepared at the indicated hours post-infection
(hpi). The lysates were subjected to Western blot analysis to detect A p-4E-BP1 and βactin, B p-p70S6K (T389), total p70S6K, ZIKV E protein, and β-actin using the
corresponding antibodies. The phospho-specific antibody against p70S6K also detected a
slower migrating p-p85S6K (T412) band (1B; top panel). C A172 cells were mockinfected (M) or infected with ZIKV at an MOI of 1 and cells lysates were prepared at the
indicated hpi. The lysates were subjected to Western blot analysis to detect p-p70S6K
(T389), total p70S6K, pAkt (S473), total Akt, ZIKV E protein, and β-actin using the
corresponding antibodies. The ratios p-p70S6K/p70S6K, p-Akt/Akt, and ZIKV E/β-actin
from these images are shown in italics. The p-p70S6K/p70S6K and p-Akt/Akt ratios in
mock-infected cells and ZIKV E/β-actin ratio in ZIKV-infected culture at 48 hpi were set
at 1. Relative electrophoretic mobility of molecular mass markers in kD is shown on the
right. nd, not determined.
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cells (Fig. 3.1A-B). Detectable levels of ZIKV envelope (E) protein were observed at 24
hpi, suggesting that viral protein expression occurred in parallel to the activation of the
mTOR signaling cascade (Fig. 3.1B). To determine if mTORC1 activation by ZIKV
infection occurs in a cell type-independent manner or is restricted to the neuronal
precursor cells, we examined the levels of p-p70S6K (T389) in A172 (human
glioblastoma) cells infected with ZIKV. Results show that the levels of p-p70S6K (T389)
were higher in ZIKV-infected A172 cells (Fig. 3.1C) than in mock-infected cells,
suggesting that mTORC1 activation by ZIKV infection is independent of the type of cells
used.
Since mTORC1 was found to be activated by ZIKV infection, we next examined
if mTORC2 was also activated by the virus infection. mTORC2 has distinct substrates
and physiological effects (Saxton and Sabatini, 2017b). Activated mTORC2
phosphorylates the downstream kinase Akt/PKB at serine 473 (S473); therefore, we
examined the levels of p-Akt (S473) in A172 cells infected with ZIKV. The results
showed a progressive increase in the levels of p-Akt (S473) with time compared to the
mock-infected cells (Fig. 3.1C), suggesting that activation of mTORC2 also occurs in
ZIKV-infected cells. Thus, the results clearly show for the first time that ZIKV infection
activates both mTORC1 and mTORC2 in different cell types, including neuronal and
glial cells in culture, and that this effect is paralleled with ZIKV protein expression.

3.3.2. ZIKV replication is dependent on mTORC1 and mTORC2 activity.
Enhanced mTOR cascade activity has been shown to be associated with both
increased and decreased viral replication (Le Sage et al., 2016). Since the previous results
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suggested that ZIKV infection activates mTOR, we next investigated whether activation
of mTORCs is required for ZIKV replication. To this end, we used Torin1 that is known
to inhibit mTOR kinase activity, potently and selectively, by an ATP-competitive
mechanism (Thoreen et al., 2009; Zask et al., 2009). To examine the effect of mTOR
kinase inhibition on ZIKV replication, cells were pretreated with or without Torin1 for 1
h followed by infection with ZIKV. The cells were then incubated in the presence of
Torin1 for 48 h. Western blot analysis of infected cell lysates showed that while the
levels of p-p70S6K (T389) were considerably higher in ZIKV-infected cells than in
mock-infected cells, the presence of Torin1 led to nearly undetectable levels of p-p70S6K
(T389) in the virus-infected cells (Fig. 3.2A). Likewise, the levels of p-Akt (S473), which
were higher in ZIKV-infected cells, were undetectable in the presence of Torin1 (Fig.
3.2A). Importantly, ZIKV E protein expression was greatly reduced in the presence of
Torin1 (Fig. 3.2A).
Examination of infectious virus yield from the infected cell culture supernatants
revealed significantly lower virus titers in cells treated with Torin1 at 48 hpi and 72 hpi
than in untreated cells (Fig. 3.2B). These results clearly demonstrated that mTOR kinase
activity is essential for viral protein expression and progeny production. Although the
virus growth at 24 hpi and 96 hpi was less in the presence of Torin1 than in its absence,
the inhibitory effect was not significant. The observed lack of significant inhibitory effect
of Torin1 at these time points could be due to the fact that ZIKV growth is not substantial
at 24 hpi, as has been seen previously (Annamalai et al., 2017), or to a decrease in the
viability of cells at 96 hpi because of virus-induced cell death. Indeed, viability of ZIKVinfected cells was significantly reduced at 96 hpi, and the presence of Torin1 reversed
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Figure 3.2: ZIKV replication requires both mTORC1 and mTORC2 activity. A
A172 cells were either left untreated (-) or pre-treated (+) with torin1 for 1 h prior to
being mock-infected or infected with ZIKV at an MOI of 1 in the continued presence of
torin1. Cell lysates were prepared at 48 hpi and subjected to Western blot analyses to
detect p-p70S6K (T389), total p70S6K, pAkt (S473), total Akt, ZIKV E protein, and βactin using the corresponding antibodies. The ratios p-p70S6K/p70S6K, p-Akt/Akt, and
ZIKV E/β-actin from these images are shown in italics. The p-p70S6K/p70S6K and pAkt/Akt ratios in mock-infected, torin1-untreated cells and ZIKV E/β-actin ratio in
ZIKV-infected, torin1-untreated culture were arbitrarily set at 1. Relative electrophoretic
mobility of molecular mass markers in kD is shown on the right. nd, not determined. B
Cell culture supernatants from untreated (vehicle) or torin1-treated and ZIKV-infected
cells were collected every 24 hpi for quantitation of virus yield by plaque assay. C Cell
viability was evaluated by flow cytometry in mock-infected (mock) and ZIKV-infected
(ZIKV) cells at 96 hpi in the presence or absence (vehicle) of torin1. Error bars represent
± SEM. ns, non-significant; ****, p ≤0.0001.
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ZIKV-induced cell death (Fig. 3.2C). These results clearly revealed an essential role for
mTOR activity in viral protein expression, infectious-progeny production, and ZIKVinduced cell death.
To determine if ZIKV replication is dependent on either mTORC1, mTORC2, or
both, we used rapamycin. Rapamycin has been reported to complex with FK506-binding
protein (FKBP), a nonobligate component of mTORC1. The FKBP-rapamycin complex
interacts with mTOR kinase and is known to inhibit its activity (Dumont and Su, 1996;
Feldman et al., 2009). A172 cells were pretreated with rapamycin for 1 h, infected with
ZIKV, and subsequently incubated in the presence of rapamycin for 48 h. We observed
that ZIKV-induced p-p70S6K (T389) was considerably reduced in the presence of
rapamycin (Fig. 3.3A, lane 4) along with reduction in the levels of the viral E protein.
While rapamycin is known to primarily inhibit mTORC1, resulting in inhibition of
p70S6K (T389) phosphorylation, it can also suppress the assembly and function of
mTORC2 upon extended exposure, leading to the inhibition of Akt phosphorylation at
S473 as well (Sarbassov et al., 2006). Accordingly, the levels of p-Akt (S473) were also
reduced in the presence rapamycin (Fig. 3.3A, lane 4), indicating that mTORC2 activity
induced by ZIKV infection is also inhibited by rapamycin. Similar to what was observed
in the presence of Torin1, culture supernatants showed significantly reduced virus titers
from infected cell culture supernatants treated with rapamycin at 48 hpi and 72 hpi (Fig.
3.3B). Again, the reduced virus yield and observed lack of significant difference in
infectious virus titers at 96 hpi was due to increased virus-induced cell death at 96 hpi,
which was prevented by rapamycin (Fig. 3.3C). Overall, these results demonstrated that
activation of mTOR signaling is required for ZIKV protein expression and virus growth.
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Figure 3.3: ZIKV replication requires both mTORC1 and mTORC2 activity. A
A172 cells were either left untreated (-) or pre-treated (+) with rapamycin for 1 h prior to
being mock-infected or infected with ZIKV at an MOI of 1 in the continued presence of
rapamycin. Cell lysates were prepared at 48 hpi and subjected to Western blot analyses to
detect p-p70S6K (T389), total p70S6K, pAkt (S473), total Akt, ZIKV E protein, and βactin using the corresponding antibodies. The ratios p-p70S6K/p70S6K, p-Akt/Akt, and
ZIKV E/β-actin from these images are shown in italics. The p-p70S6K/p70S6K and pAkt/Akt ratios in mock-infected, rapamycin-untreated cells and ZIKV E/β-actin ratio in
ZIKV-infected, rapamycin-untreated culture were arbitrarily set at 1. Relative
electrophoretic mobility of molecular mass markers in kD is shown on the right. nd, not
determined. B Cell culture supernatants from untreated (vehicle) or rapamycin-treated
and ZIKV-infected cells were collected every 24 hpi for quantitation of virus yield by
plaque assay. C Cell viability was evaluated by flow cytometry in mock-infected (mock)
and ZIKV-infected (ZIKV) cells at 96 hpi in the presence or absence (vehicle) of
rapamycin. Error bars represent ± SEM. ns, non-significant; ****, p ≤0.0001.
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However, the pharmacological inhibition of mTOR signaling was inconclusive with
regard to whether activation of either mTORC1 or mTORC2 is required for virus
replication.

3.3.3. Both mTORC1 and mTORC2 are required for ZIKV replication.
To unequivocally examine the role of mTOR in ZIKV replication, we conducted
experiments in which critical protein components of the mTORC1, mTORC2, or both
were depleted. Since the mTOR kinase is the central component of both complexes,
whereas Raptor and Rictor are the unique scaffolding subunits of mTORC1 and
mTORC2, respectively, we used specific small interfering RNAs (siRNAs) against the
proteins to deplete the cells of these proteins and examine the effects on ZIKV E protein
expression and progeny production. In cells transfected with siRNA targeting mTOR
kinase, the levels of mTOR protein were greatly reduced compared to that seen with nontargeting (NT) siRNA (Fig. 3.4A, lanes 3 and 4). Similarly, when siRNAs targeting
Raptor (Fig. 3.4A, lanes 7 and 8) or Rictor (lanes 5 and 6) were used, depletion of the
corresponding proteins was also observed. Importantly, the reduction in these protein
levels was associated with downregulation of phosphorylation of the corresponding
substrates: p70S6K for mTORC1 (Raptor) (Fig. 3.4B, lanes 7 and 8) and Akt for
mTORC2 (Rictor) (Fig. 3.4B, lanes 5 and 6). These results corroborate that siRNAmediated depletion of Raptor or Rictor leads to significant downregulation of the
activities of mTORC1 or mTORC2.
In cells infected with ZIKV, a dramatic reduction in the levels of E protein was
observed when mTOR kinase was depleted (Fig. 3.5A, compare lane 4 with lane 2),
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Figure 3.4: siRNA mediated depletion of mTOR complex 1 (mTORC1) and 2
(mTORC2) components. A A172 cells were transfected with either non-targeting (NT)
siRNA or siRNAs targeting mTOR kinase (mTOR), Rictor or Raptor for 72 h and mockinfected (M) or infected with ZIKV for 48 h. Cell lysates were prepared and subjected to
Western blot analyses to detect mTOR, Raptor, Rictor, and β-actin using the
corresponding antibodies. The ratios mTOR/β-actin, Rictor/β-actin, and Raptor/β-actin,
from these images are shown in italics. The ratios for mTOR/β-actin, Rictor/β-actin, and
Raptor/β-actin from uninfected and NT siRNA-treated cells were set at 1. Relative
electrophoretic mobility of molecular mass markers in kD is shown on the right. B Cell
lysates from the same experiment were subjected for Western blot analysis to detect pp70S6K (T389), total p70S6K, pAkt (S473), total Akt, and β-actin using the
corresponding antibodies. The ratios p-p70S6K/p70S6K and p-Akt/Akt, from these
images are shown italics.
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Figure 3.5: mTOR complex 1 (mTORC1) and 2 (mTORC2) regulate ZIKV
replication. A A172 cells were transfected with either non-targeting (NT) siRNA or
siRNAs targeting mTOR kinase (mTOR), Rictor or Raptor for 72 h and mock-infected
(M) or infected with ZIKV for 48 h. Cell lysates were prepared and subjected to Western
blot analyses to detect ZIKV E and β-actin using the corresponding antibodies. The ratios
ZIKV E/β-actin from these images are shown in italics. The ratio for ZIKV/β-actin, from
infected and NT siRNA-treated cells were set at 1. Relative electrophoretic mobility of
molecular mass markers in kD is shown on the right. B Infectious virus production in
cells depleted of mTOR, Rictor, or Raptor. The experiments were conducted as described
in panel A, culture supernatants from infected cells were collected at various hpi and
assayed for infectious virus yield by plaque assay. Horizontal discontinuous line
represents limit of detection. #, virus titer is below the limit of detection. Error bars
represent ± SEM. a, two-way ANOVA, p ≤0.0001; ****, p ≤0.0001.
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consistent with the results in Fig. 3.2 and 3.3 obtained with the use of Torin1 and
rapamycin, respectively. When Raptor (Fig. 3.5A, lane 8) or Rictor (lane 6) was depleted
from the cells through the use of the corresponding siRNAs, the levels of the viral E
protein in these infected cells were also dramatically reduced. These results suggest that
both mTORC1 and mTORC2 are necessary for optimal levels of viral protein expression.
It is interesting to note that while the depletion of Raptor led to nearly undetectable levels
of E protein expression (Fig. 3.5A, lane 8), the depletion of Rictor led to detectable but
significantly reduced (lane 6) levels of the viral E protein expression. These results show
that the requirement for mTORC1 in viral E protein expression is more important than
the requirement for mTORC2. However, the role of mTORC2 as a critical regulator of
ZIKV replication cannot be ignored.
Consistent with drastic reduction in viral E protein expression, we also observed
significant reduction in infectious progeny production in cells with depleted mTOR
kinase, Raptor, or Rictor (Fig. 3.5B). Although depletion of mTOR kinase or Rictor led
to levels of production of infectious progeny that were significantly lower than those in
cells treated with NT siRNA, the effect of Raptor depletion was most dramatic in that
infectious virus production was below the level of detection at 24, 48, or 72 hpi, whereas
at 96 hpi, the virus titers were significantly lower than those from NT siRNA-treated cells
(Fig. 3.5B). Thus, these results show that both mTORC1 and mTORC2 are required for
ZIKV protein expression and infectious virus production; however, mTORC1 appears to
play a more important role in these processes than mTORC2.
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3.3.4. ZIKV infection induces autophagy, which suppresses the virus replication.
As mTOR signaling is known to regulate autophagy (Ganley et al., 2009), a
cellular homeostatic pathway that can also function as an antiviral response to virus
infection (Lee and Iwasaki, 2008), we investigated the role of autophagy in ZIKV
infection. Flaviviruses, including ZIKV, infection is known to activate autophagy (Ke,
2018; Liang et al., 2016). Microtubule-associated protein 1A/1B-light chain 3 (LC3) is a
soluble protein that is recruited to autophagosomal membranes and is commonly used as
a marker for changes in autophagosome dynamics. Therefore, we examined the
distribution of LC3 in cells infected with ZIKV at various times points post infection.
Human neuroblastoma SK-N-SH cells stably expressing LC3 labeled with enhanced
green fluorescent protein (EGFP-LC3) (Garcia-Garcia et al., 2013) were mock infected or
infected with ZIKV (Fig. 3.6A). Following incubation for indicated lengths of time, the
cells were either untreated or treated with chloroquine (CQ) 4 h prior to the termination
of the experiment to avoid any unintended negative effects of CQ on ZIKV infection and
block autophagosome cargo degradation (Delvecchio et al., 2016). The cells were
subsequently stained with LysoTracker Red (a marker for lysosomes) and examined by
fluorescence microscopy. Results showed that ZIKV infection significantly increased the
accumulation of EGFP-LC3 punctum clusters at 12 and 24 hpi compared to mock
infected cells in the presence or absence of CQ, an inhibitor of lysosomal cargo
degradation (Fig. 3.6A-B). These results suggest that ZIKV infection increases autophagy
flux at early time points of infection.
To corroborate these observations, we evaluated changes in the levels of lipidated
LC3-II and the levels p62, an autophagy receptor with the ability to co-aggregate in the
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Figure 3.6: Autophagy is induced in cells infected with ZIKV. A SK-N-SH cells
stably expressing EGFP-LC3 were mock-infected or infected with ZIKV at an MOI of 1.
The cells were left untreated or treated with CQ for 4 h prior to the termination of the
experiment followed by staining with LysoTracker Red before being examined by
fluorescence microscopy. Arrowheads in merged images indicate EGFP-LC3 puncta
clusters. Arrows indicate enlarged cells with higher abundance of EGFP-LC3 clusters.
Scale bar: 10 µm. B Quantification of EGFP-LC3 puncta per cell (n ≥ 37) from three
representative fields is shown. Error bars represent ± SEM. One-Way ANOVA on Ranks;
***, p ≤0.001.
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presence of ubiquitinated substrates (Lamark et al., 2017). A172 cells infected with ZIKV
showed an early increase in the levels of p62 monomers as well as aggregates at 12 and
24 hpi in comparison to mock infected cells (Fig. 3.7A). Interestingly, the p62 levels
decreased over time, and by 48 hpi, they were comparable to those in mock-infected cells
(Fig. 3.7A). The levels of p62 aggregates were also similar to that of monomeric p62 at
the indicated times post ZIKV infection. Similarly, an increase in LC3-II level was
observed between 12 and 24 hpi, which decreased at later time points (Fig. 3.7A). These
results clearly show that ZIKV infection results in activation of autophagy at early times
after infection and is suppressed as infection proceeds. In the presence of CQ, the levels
of p62 and LC3-II increased slightly further in the infected cells at 12 hpi (Fig. 3.7B, lane
6) in comparison to mock-infected cells (lane 2) and tapered off at later times post
infection. These results corroborate that ZIKV infection induces an increase in autophagy
flux at early times (12 to 24 h) following infection. To assess the effect of autophagy
induction on viral protein expression, we examined the levels of viral E protein
expression in cells infected with ZIKV in the presence or absence of 3-methyladenine (3MA), a purine analog known to block autophagosome elongation by inhibiting the class
III PI3K signaling cascade (Petiot et al., 2000; Seglen and Gordon, 1982). Inhibiting
autophagy by 3-MA resulted in the accumulation of p62 that was paralleled by a decrease
in the levels of lipidated LC3-II in infected and mock-infected cells (Fig. 3.8A).
Importantly, we observed that there was an increase in the accumulation of viral E
protein in infected cells treated with 3-MA compared to cells not treated with 3-MA (Fig.
3.8A), which suggests that autophagy prompts the degradation of viral treated with 3-MA
compared to untreated cells (Fig. 3.8B). Taken together, these results show that early
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Figure 3.7: ZIKV induced autophagy. A A172 cells were either mock-infected (M) or
infected with ZIKV at an MOI of 1. Cell lysates were prepared at various hpi, subjected
to Western blot analysis to detect levels of p62 and LC3-II using corresponding
antibodies. Monomeric p62 levels are presented on top panel. A longer exposure of the
same blot showing the p62 monomer as well as the p62 aggregates towards the top of the
blot is shown in the panel below that. Ratios of p62 monomer/β-actin, p62 aggregates/βactin, and LC3-II/β-actin are shown in italics with the ratios in mock-infected culture set
arbitrarily at 1. Relative electrophoretic mobility of molecular mass markers in kD is
shown on the right. B A172 cells were either mock-infected (M) or infected with ZIKV at
an MOI of 1. CQ was added 4 h prior to harvesting cell lysates at the indicated time
points. Levels of p62, LC3-II, and β-actin were analyzed by Western blotting.
Representative image from three independent experiments is shown. Ratios of p62/βactin, and LC3-II/β-actin are shown in italics with the ratios in mock-infected culture set
arbitrarily at 1.
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Figure 3.8: ZIKV-induced autophagy suppresses virus replication. A A172 cells were
mock-infected (M) or infected with ZIKV at an MOI 1 in the presence (+) or absence (-)
of 3-MA, cell lysates were prepared at the indicated time points and the levels of p62,
LC3-II, viral E protein, and β-actin were examined by Western blot analysis. Ratios of
p62/β-actin, LC3-II/β-actin and ZIKV E/β-actin are shown in italics with the ratios set
arbitrarily at 1 as shown. B Infectious progeny virus titers as determined by plaque assay
from ZIKV-infected cells untreated (Vehicle) or treated with 3-MA. Error bars represent
± SEM. *, p ≤ 0.05; ****, p ≤ 0.0001.
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induction of autophagy upon ZIKV infection (12 to 24 hpi) is indeed a cellular defense
mechanism that suppresses viral protein accumulation and progeny production, but at
later stages in ZIKV infection (

24 hpi), autophagy is suppressed to allow ZIKV protein

accumulation and progeny production.

3.3.5. mTOR activation suppresses autophagy and allows ZIKV replication.
I next wanted to investigate if the role of mTOR in the regulation of viral protein
expression and progeny production is linked to autophagy. mTORC1 has been shown to
phosphorylate ULK1 at serine 757 (S757) to negatively regulate autophagy (Kim et al.,
2011). To this end, we examined cell lysates of ZIKV-infected cells harvested at different
times following infection for the expression of p-ULK1 (S757). The results showed an
increase in the levels of p-ULK1 (S757) with time after the virus infection (Fig. 3.9A)
that parallels the gradual decline in the levels of p62 and LC3-II (Fig. 3.7A), suggesting
that ZIKV-induced phosphorylation of ULK1 suppresses autophagy. Accordingly,
inhibition of mTORC1 by Torin1 ablated ULK1 phosphorylation (Fig. 3.9B) with a
concomitant increase in autophagy, as evidenced by the enhanced degradation of p62 and
LC3-II (Fig. 3.9B). As shown before, the level of ZIKV E protein was reduced
substantially in the presence of Torin1 (Fig. 3.9B). These results suggest that during
ZIKV infection, phosphorylation, and the subsequent inhibition of ULK1 by mTOR
inhibit autophagy and facilitate ZIKV E protein accumulation.
Since inhibiting mTOR kinase resulted in increased autophagy with a concomitant
decrease in viral E protein levels, we wanted to investigate if inhibiting autophagy with
3-MA (class III PI3K inhibitor) or MRT6891 (ULK1 inhibitor) under conditions in which
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Figure 3.9: ZIKV infection induces ULK1 phosphorylation and suppresses
autophagy. A Phosphorylation of ULK1 is enhanced in ZIKV-infected cells. A172 cells
were either mock-infected (M) or infected with ZIKV at an MOI of 1. Cell lysates were
prepared at various hpi and subjected to Western blot analysis for p-ULK (S757), total
ULK1 and β-actin. Ratio of p-ULK1/ULK1 is shown in italics with the ratio in mockinfected culture set arbitrarily at 1 B Inhibition of mTORC1 by torin1 leads to reduced
ULK1 phosphorylation and reduced detection of the viral E protein. A172 cells treated
with (+) or without (-) torin1 were mock-infected (M) or infected with ZIKV. Cell
extracts were prepared at 49 hpi and the levels of p-ULK1 (S757), total ULK, p62, LC3II, ZIKV E protein, and β-actin were examined by Western blotting. Ratios of pULK1/ULK1, p62/β-actin, LC3-II/β-actin and ZIKV E/β-actin are shown in italics with
the ratios set arbitrarily at 1 as shown.
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mTOR kinase activity has already been impaired would result in rescue of viral E protein
levels and infectious-progeny production. Data from such an experiment would provide
unequivocal evidence for a direct link between mTOR activation, suppression of
autophagy, and viral replication. The enhanced autophagy induced by Torin1, as
evidenced by the increased degradation of p62 and LC3-II, was reversed by 3-MA (Fig.
3.10A, compare lanes 3 and 4 with lanes 9 and 10) or MRT68921 (Fig. 3.10A, compare
lanes 3 and 4 with lanes 11 and 12) in cells infected with ZIKV or left uninfected.
However, only in cells infected with ZIKV did 3-MA and MRT68921 prevent the
decrease in E protein levels induced by Torin1 (Fig. 3.10A, compare lane 4 with 10 and
lane 4 with 12). Furthermore, infectious virus production, which is also inhibited
significantly in the presence of Torin1, was seen to be rescued to the untreated-control
levels in the presence of 3-MA or MRT68921 (Fig. 3.10B). Overall, these observations
clearly show that activation of mTOR in ZIKV infected cells suppresses autophagy to
allow virus protein expression and progeny production.

3.4. Discussion
Studies have demonstrated that ZIKV infection hinders growth and development
of neurospheres and organoid cultures in vitro (Garcez et al., 2016; Garcez et al., 2017;
Qian et al., 2017). It has also been demonstrated that ZIKV infection causes abnormal
neurological development and fetal demise in mice (Lazear and Diamond, 2016; Li et al.,
2016a; Miner et al., 2016). Yet, the molecular mechanisms of ZIKV induced
pathogenesis are not entirely understood. mTOR signaling is critically involved in and
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Figure 3.10: Inhibition of autophagy under condition of mTORC inhibition rescues
ZIKV replication. A and B Inhibiting autophagy under condition of mTORC inhibition
rescues viral E protein accumulation A and progeny production B. A172 cells were either
mock-infected (-) or infected with ZIKV (+) and treated without (-) or with (+) various
inhibitors as shown on top of each lane in panel A. Cell extracts were prepared at 48 hpi
and analyzed by Western blotting for p62, LC3-II, ZIKV E protein, and β-actin. Ratios of
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p62/β-actin, LC3-II/β-actin, and ZIKV E/β-actin are shown in italics with the ratios set
arbitrarily at 1 as shown. Under similar experimental conditions, culture supernatants
from the infected cells at 72 hpi were assayed for infectious progeny production B by
plaque assay. Error bars represent ± SEM. ***, p ≤0.001.
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regulates many cellular processes such as growth, survival, and proliferation (Saxton and
Sabatini, 2017a).
Many viruses are known to either activate or suppress mTORC signaling to
facilitate viral replication (Le Sage et al., 2016). Additionally, prototypic flaviviruses
such as the WNV, DENV, Japanese encephalitis virus (JEV) and hepatitis C virus (HCV)
are known to activate the Akt/mTOR pathway and this activation may be proviral or an
antiviral role in nature (Le Sage et al., 2016). While inhibition of mTOR activates
autophagy and enhances DENV replication (Jan et al., 2016), mTORC1 supports WNV
replication (Shives et al., 2014). With regard to HCV, the role of mTOR appears to be
controversial in that some studies suggest a proviral role of mTOR activation (Peng et al.,
2010; Stohr et al., 2016) while others advocate for an antiviral role (Johri et al., 2019;
Shao et al., 2010; Shrivastava et al., 2012). Additionally, activation of mTOR and
mTOR-dependent mechanisms have been implicated in the enzootic transmission cycle
of some flaviviruses involving the mosquito vector (Hansen et al., 2004). Therefore,
modulation of mTOR signaling appears to be integral to flavivirus transmission,
replication, and pathogenesis.
Using human neuronal progenitor (LUHMES) and glioblastoma (A172) cells, we
observed activation of mTORC1 following infection with ZIKV. Further studies revealed
that ZIKV infection activated not only mTORC1 but also mTORC2 to facilitate viral
protein expression, accumulation, and progeny virus production. These studies also
revealed that early during ZIKV infection, autophagy is activated that results in the
restriction of viral protein accumulation to undetectable levels but at later times,
autophagy is suppressed by the inhibitory phosphorylation of ULK1 via activation of
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Figure 3.11: Scheme of ZIKV-induced regulation of autophagy, mTOR signaling,
and effects on viral protein accumulation, progeny virus production and cell death
in infected cells. (A) ZIKV infection induces an early activation of autophagy (≤ 24 hpi)
that mediates the degradation of viral proteins preventing viral assembly. (B) Later stages
of infection (≥ 24 hpi) activate mTORC1 and mTORC2 to mediate the phosphorylation
and inhibition of ULK1, whose activity is necessary for autophagy initiation. Inhibition
of autophagy facilitates accumulation of viral proteins, infectious progeny release, and
cell death. The timeframe of the events delineated here is likely dependent on the cell
type for infection, the exposure time and dosage of the virus.
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mTORC1. This leads to increased levels of viral protein accumulation in the infected
cells and enhanced viral progeny production.
ZIKV infection induces autophagy (Cao et al., 2017; Cugola et al., 2016; Hamel
et al., 2015) but there are conflicting results as to the effect of autophagy on ZIKV
infection. Some studies report that inhibition of autophagy reduces viral replication and
limits viral transmission (Abernathy et al., 2019; Cao et al., 2017; Hamel et al., 2015).
ZIKV-induced autophagy was also shown to be mediated by inhibition of the Akt-mTOR
pathway by the viral NS4A and NS4B proteins, leading to defective neurogenesis (Liang
et al., 2016). In contrast, other studies have reported that autophagy facilitates virus
clearance in phagocytes (Huang et al., 2020) and protects cells against ZIKV infection
(Karuppan et al., 2020; Liu et al., 2018). On the other hand, pharmacological and genetic
inhibition of autophagy was shown to have no adverse effect on ZIKV replication in glial
cells (Ojha et al., 2019).
While the conflicting findings in regard to the role of autophagy and mTOR in
ZIKV infection could be attributed to the different cell types and experimental model
systems that these cellular events were tested in, it could also be linked to the temporality
of the events being analyzed. In addition, the experimental tools used to study mTOR
signaling might be a point of discrepancy. While phosphorylation of mTOR at S2448 has
been used in many studies as a marker for mTOR activation, there is clear evidence that
pS2448 does not correlate with mTOR activity (Figueiredo et al., 2017). Using different
cell types, we demonstrated that mTORC1 and mTORC2 are consistently activated by
evaluating the phosphorylation status of their direct substrates, p70S6K, ULK1
(mTORC1) and Akt (mTORC2), which are considered as more reliable readouts of
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mTOR activation (Saxton and Sabatini, 2017a). We have clearly defined that while
autophagy is initiated early during the infection process, it is later on suppressed by
ZIKV-induced mTOR activation. Very few studies have addressed the time-course of
changes in such events and thus point to the importance of these results.
The role of the individual complexes in ZIKV protein expression and progeny
production could not be ascertained using torin1 or rapamycin due to the lack of
specificity of these compounds. By using siRNAs to deplete the critical components of
the two complexes, we was able to firmly conclude that both mTORC1 and mTORC2 are
required for efficient ZIKV replication, although a differential effect was noted in their
requirements. mTORC1 appears to play a more dominant role in ZIKV replication
compared to mTORC2. This is borne out from the observations that Raptor depletion led
to extremely low to undetectable levels of viral protein expression and infectious progeny
production (Fig. 3.5), while Rictor depletion led to significantly reduced but still
detectable levels of E protein expression and progeny production.
Several studies have provided evidence for a major role for mTORC1 in virus
replicative processes, but the role for mTORC2 has been less clear. Replication of WNV,
HCV, influenza virus, Andes virus and herpesviruses require mTORC1 but not mTORC2
(Clippinger et al., 2011; Kuss-Duerkop et al., 2017; McNulty et al., 2013; Moorman and
Shenk, 2010; Shives et al., 2014; Stohr et al., 2016). Only one previous study showed that
Rictor (mTORC2) is primarily involved in HCMV replication (Kudchodkar et al., 2006).
Although the NS5A protein of HCV activates mTORC2 (George et al., 2012), no
experimental evidence links this activation to viral replication. Therefore, one important
finding from my studies reported here is the significant involvement of mTORC2 in
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replication of ZIKV. The mTORC2 may play an indirect role, likely upstream of
mTORC1 activation through phosphorylation of Akt, an activator of mTORC1
(Sarbassov et al., 2005). Since a negative feedback loop between mTORC1 activation
and mTORC2 has been described where p70S6K phosphorylates Rictor and decreases
mTORC2 function (Efeyan and Sabatini, 2010; Julien et al., 2010), it is possible that
ZIKV also overcomes this negative feedback loop to facilitate the potentiation of
mTORC1 activation by mTORC2.
It is interesting to note that depletion of mTOR kinase itself resulted in still
detectable levels of E protein expression and progeny production, while knockdown of
Raptor exerted a more robust negative effect. Knockdown of Rictor induced a more
pronounced decrease in Akt phosphorylation than mTOR downregulation (Fig. 3.4).
Since mTOR kinase is central to both mTORC1 and mTORC2, our expectation was that
depletion of mTOR would have the most significant negative impact on viral E protein
expression and progeny production as well as on the corresponding downstream
substrates compared to the Raptor or Rictor depletion. A direct comparison between the
knockdown of mTOR, Rictor, and Raptor cannot be made by just comparing the changes
in protein levels or the phosphorylation of the corresponding substrates as this would
require that the antibodies used for detection had similar signal-to-noise ratio efficiencies.
However, a possibility exists that Raptor might partially regulate ZIKV replication
independent from mTOR. Indeed, a recent study reports mTOR-independent functions
for Raptor (Kim et al., 2016). Similarly, Rictor has been shown to form mTOR-less
complexes that mediate different processes including Akt phosphorylation (Gkountakos
et al., 2018; McDonald et al., 2008). To address an mTOR-independent role of Raptor
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and Rictor in ZIKV infection is an interesting area of research that requires further
experimentation.
The inability to detect viral proteins in ZIKV-infected cells prior to 24 hpi was
surprising given that the viral genome is a competent template for translation
immediately after entry into cells. We considered the possibility that autophagy was
being activated early in ZIKV infected cells resulting in inhibition of viral protein
accumulation to undetectable levels. Flaviviruses are known to activate autophagy, which
plays an important role in replication and/or pathogenesis (Ke, 2018). For example, the
viral NS4A-induced autophagy protects DENV- and Modoc virus (a murine flavivirus)infected cells and enhances virus replication (McLean et al., 2011) whereas ZIKV NS4Aand NS4B-induced autophagy inhibits neurogenesis (Liang et al., 2016). Autophagy is
also induced in DENV- and HCV-infected cells to support viral replication (Chu et al.,
2014; Dreux et al., 2009) while in a separate study, autophagy was found to play no role
in WNV infection (Beatman et al., 2012).
Our results (Fig. 3.7) show that autophagy was indeed induced early (within 24
hpi) in ZIKV-infected cells and thereafter there was a gradual decline in the autophagy
flux. The decline in autophagy flux was concomitant with increase in mTOR activation as
seen by increased phosphorylation of ULK1. In addition to p-ULK1, mTORC1 activation
has been shown to inhibit autophagy at other signaling steps, so we cannot rule out other
targets that mediate the negative regulation of autophagy by ZIKV-induced mTORC1
activation (Kim and Guan, 2015). Based on the findings reported here, we propose that
activation of autophagy is an early antiviral response against ZIKV infection (Fig. 3.11A)
that is then suppressed by the virus-induced activation of mTORC signaling, leading to
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enhanced viral protein accumulation and progeny production (Fig. 3.11B). However, it is
important to recognize that the temporality of these events might change depending on
the cell types or experimental model systems used and the conditions of infection
including virus dose and length of infection. While inhibition of autophagy increased
viral protein accumulation, it only occurred at 24 hpi, which also suggests the existence
of other unexplored mechanisms by which the cell limits viral replication at early time
points of infection.
The mechanisms involved in autophagy activation by ZIKV are incompletely
understood. Although NS4A and NS4B proteins have been shown to induce autophagy
through inhibition of mTOR signaling (Liang et al., 2016), we have observed that the
induction of autophagy precedes viral protein accumulation with no evidence of
inhibition of mTOR signaling. A recent report demonstrated that ZIKV induces an NFκB-dependent autophagy pathway mediated by STING (Liu et al., 2018). Another report
demonstrates that in astrocytes activation of NF-κB and autophagy by ZIKV infection
seems to depend on TL3 receptors (Ojha et al., 2019). Thus, autophagy could be triggered
by the induction of antiviral innate immune responses prior to viral replication. It is also
possible that adenosine-monophosphate (AMP)-activated kinase (AMPK), which is
activated by ZIKV (Thaker et al., 2019a) could induce autophagy. It is unknown at this
time what viral factors drive activation of autophagy early in infection and mTORC
signaling. However, we have observed that autophagy is not activated when UVinactivated ZIKV is used in the experiments, suggesting that live virus infection is
necessary. Which antiviral immune responses and viral structural and/or non-structural
proteins are involved in the activation of autophagy and the later induction of mTOR
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signaling are not known at this time and remains to be investigated. Bystander effects
from infected cells could also contribute to the modulation of autophagy. Indeed,
previous reports have demonstrated that the release of soluble factors including cytokines
can regulate autophagy in non-infected cells (Kong et al., 2018; Van Grol et al., 2010;
Wu et al., 2016).
Since hyperactive mTOR signaling is linked to exhaustion of stem cell niches and
loss of mTOR activity leads to depletion of progenitor cells responsible for the normal
development of the brain (Takei and Nawa, 2014), these results might also point to
potential mechanism(s) of ZIKV-induced neurological deficits in developing fetal brains.
Further exploration in this aspect can provide a better understanding into the molecular
mechanism(s) of ZIKV induced microcephaly and other neurological deficits.
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CHAPTER 4: REDOX REGULATION OF ZIKA VIRUS REPLICATION

4.1. Abstract
ZIKV is a mosquito-transmitted flavivirus and its association with microcephaly,
other congenital abnormalities in the developing fetus and Guillain-Barré syndrome,
neuropathy, and myelitis in adults and older children is a major concern to public health.
The molecular machinery regulating ZIKV infection are still unclear. While it is well
known that viral infections alter host cell redox homeostasis that can either be pro-viral or
anti-viral in nature, exact mechanisms and consequences for different viruses are not
clearly understood. The results show that ZIKV infection induces oxidative stress in
neuronal and glial cells in culture which transiently activates the nuclear factor erythroid
2 p45-related transcription factor 2 (Nrf2) signaling cascade. We demonstrate that
downregulation of Nrf2 or inhibition of de novo GSH synthesis was shown to increase
viral protein synthesis and infectious particle production. Additionally, depletion of the
enzymes, glucose 6-phosphate dehydrogenase (G6PD) and 6-phosphogluconate
dehydrogenase (6PGD), critical contributors to the generation of NADPH increased viral
replication. Although pharmacologic inhibition of G6PD and 6PGD by 6-amino
nicotinamide (6-AN) resulted in significant inhibition of viral protein synthesis and
infectious progeny production, the inhibition could not be rescued by D-ribose, indicating
that pentose phosphate pathway (PPP) does not appear to play a major role in viral
replication. These results highlight the importance of cellular redox homeostasis in the
regulation of ZIKV replication.
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4.2. Introduction
Several studies have shown that prototypic flaviviruses including HCV, DENV as
well as JEV induce oxidative stress upon infection and which correlates with disease
pathogenesis (Gil et al., 2004; Korenaga et al., 2005; Liao et al., 2002; Zhang et al.,
2019). Upon infection, the virus hijacks host cell metabolism which triggers stress on the
cell. Generally, cellular metabolism leads to the generation of reactive oxygen species
(ROS) such as superoxide anion (O2•−), singlet oxygen (1O2) and hydrogen peroxide
(H2O2) in mitochondria, ER, and peroxisomes. These ROSs at moderate levels can serve
as critical cofactors in cellular signaling and are promptly neutralized by antioxidant
defense system (Birben et al., 2012). But in an infected cell, the redox homeostasis is
altered by virus induced metabolic changes and resulting in the induction of oxidative
stress (Zhang et al., 2019).
Increased oxidative stress can have a multitude of consequences including lipid
peroxidation, protein carbonyl formation, DNA damage and activates multiple stress
induced transcription factors that further downregulate antioxidant response and amplify
oxidant induced cellular damage (Birben et al., 2012; Cooke et al., 2003; Dalton et al.,
1999). It has been shown that the induction of oxidative stress can be beneficial to viral
replication in host cells. Flaviviruses are known to control 5’ RNA genome capping by
inducing oxidative stress in infected cells (Gullberg et al., 2015). Dengue virus (DENV)
is known to induce oxidant-triggered autophagy in infected cells leading to inhibition of
apoptotic cell death and increased viral replication (Datan et al., 2016). Additionally,
DENV infection has been reported to reduce cellular GSH pool, which generally
downregulates ROS and maintains redox homeostasis and pharmacological inhibition of
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GSH synthesis enhanced viral replication (Tian et al., 2010). HCV causes chronic
hepatitis in infected patients by triggering oxidative stress and downregulating
antioxidant response (Ivanov et al., 2013; Rebbani and Tsukiyama-Kohara, 2016; Vasallo
and Gastaminza, 2015).
The nuclear factor erythroid 2–related transcription factor 2 (Nrf2) signaling
cascade is a key player in the cellular antioxidant system (Hayes and Dinkova-Kostova,
2014). When the redox homeostasis is maintained, Nrf2 stably associates with kelch-like
ECH- associated protein 1 (Keap1) and is constitutively ubiquitinated and degraded via
the ubiquitin- proteasome pathway (Cullinan et al., 2004; Hayes and Dinkova-Kostova,
2014). Upon oxidative stress induction, stable association of Nrf2 and Keap1 is altered by
conformational changes in Keap1 leading to its dissociation and resultant activation of
Nrf2 (Cullinan et al., 2004; Hayes and Dinkova-Kostova, 2014). Subsequently, the
heterodimerization of Nrf2 with small Maf (sMaf) proteins leads to nuclear translocation
of Nrf2 where it induces the activation of antioxidant response elements (AREs), a cluster
of genes involved in antioxidant response, cellular protection, and regulation of
autophagy (Hayes and Dinkova-Kostova, 2014; Pajares et al., 2016; Pajares et al., 2018).
Additionally, Nrf2 is involved in the de novo synthesis of GSH, an important intracellular
antioxidant, by directly modulating the activity of Glutamate-Cysteine Ligase Catalytic
subunit (GCLC), and reduced Nicotinamide adenine dinucleotide phosphate (NADPH),
by inducing the activity of the enzymes G6PD and 6PGD (Hayes and Dinkova-Kostova,
2014).
Although few studies have implicated the induction of oxidative stress in ZIKV
infected cells, a detailed understanding of the molecular mechanisms involved therein is
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poorly understood. In this study, we demonstrate that ZIKV infection of neuronal and
glial cells in culture results in the induction of oxidative stress that triggers transient
activation of Nrf2 signaling cascade. The activation of Nrf2 is found to be antagonistic to
ZIKV replication since its depletion promotes ZIKV protein synthesis and infectious
virion production. Furthermore, transient activation of Nrf2 in ZIKV infected cells leads
to the activation of its downstream effectors, GCLC and G6PD which are known to be
involved in the synthesis of glutathione (GSH) and generation of NADPH, critical
contributors to the cell’s antioxidant system. Both, inhibition of de novo GSH synthesis
by BSO or depletion of NADPH generating enzymes, G6PD or 6PGD, resulted in
enhanced ZIKV replication. These results highlight the antiviral role played cellular
antioxidant response in ZIKV infection.

4.3. Results
4.3.1. ZIKV infection induces oxidative stress in neuronal and glial cells in culture
ZIKV has been reported to have a wide cellular tropism (Lazear and Diamomd,
JVI review in 2016?) and is known to infect cells of neuronal origin. Using the neuronal
progenitor LUHMES cells, we first sought to determine the susceptibility of these cells to
ZIKV infection as it had not been reported previously. Immunofluorescence imaging for
ZIKV E protein shows that LUHMES are permissive to infection by ZIKV, and this is
dependent on the multiplicity of infection (MOI) (Fig. 4.1A). Western blot analysis
revealed that the expression of ZIKV E protein in LUHMES cells was also MOIdependent (Fig. 4.1B).
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Figure 4.1: ZIKV infection induces oxidative stress in LUHMES cells. A Cells were
either mock-infected (M) or infected with ZIKV at the indicated MOI and at 24 hpi, the
cells were fixed and stained with anti-flavivirus E antibody followed by Alexa 488
conjugated secondary antibody. Fluorescence images show cells infected with ZIKV
(green) at indicated MOIs. B Cells were either mock-infected (M) or infected with ZIKV
at the indicated MOI and at 24 hpi, lysates were prepared and subjected to Western blot
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analysis to detect ZIKV E protein and β-actin using the corresponding antibodies.
Relative electrophoretic mobility of molecular mass markers in kilo Daltons (kD) is
shown on the right. Flowcytometry analysis show the MOI dependent induction of
mitochondrial C and cytosolic D oxidative stress measured using MitoSox and
Dihydroethidium (DHE) respectively in mock-infected vs ZIKV-infected cells . (E)
Flowcytometry analysis show the MOI dependent reduction on Glutathione content in
ZIKV-infected vs mock-infected cells.
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Additionally, ZIKV infection triggered an MOI dependent increase in ROS, both
mitochondrial (Fig. 4.1C) and cytosolic (Fig. 4.1D), which was paralleled with the
reduction of cellular GSH content (Fig. 4.1E). Similarly, infection of A172 human
glioblastoma cells led to expression of viral E protein which was detectable at 24 hpi with
a maximal expression between 48 and 72 hpi (Fig. 4.2A). The virus infection also led to
an increase in the accumulation of mitochondrial ROS that is evident at 48 hpi (Fig. 4.2B
and C) and increased significantly by 72 hpi. A parallel significant reduction in cellular
GSH content was also evident at 72 hpi in infected cells (Fig. 4.2D and E). These results
unequivocally demonstrate that ZIKV infection induces oxidative stress in neuronal
precursor and glial cells.

4.3.2. Nrf2 activation precedes oxidative stress and antagonizes viral replication
Previous studies have demonstrated that ZIKV induces oxidative stress (Almeida
et al., 2020; Ledur et al., 2020; Li et al., 2017a; Simanjuntak et al., 2018), but conflicting
results exist in regards to the activation of the antioxidant response by Nrf2 (Almeida et
al., 2020). Nrf2 is a functionally active transcription factor constitutively expressed in the
cell. However, under normal conditions of cell growth, it is negatively regulated by its
ubiquitination and degradation via the proteasome. Nrf2 degradation is interrupted upon
oxidative stress to become stabilized and transcriptionally active (Nguyen et al., 2009). In
contrast to ROS formation, ZIKV induced an early stabilization of Nrf2 at 12 hpi that
peaked between 24-48 hpi (Fig. 4.3). In mock-infected cells, Nrf2 was undetectable (Fig.
4.3, lane 1). This is likely attributed to the observation that under normal conditions Nrf2
has a short lifespan and is degraded rapidly in cells
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Figure 4.2: ZIKV infection induces oxidative stress in A172 cells. A Cells were either
mock-infected (M) or infected with ZIKV at MOI 1 and at the indicated hpi, lysates were
prepared and subjected to Western blot analysis to detect ZIKV E protein and β-actin
using corresponding antibodies. Relative electrophoretic mobility of molecular mass
markers in kD is shown on the right. B Flowcytometry analysis show time-dependent
induction of mitochondrial oxidative stress C and D measured using MitoSox and GSH
content E and F in mock-infected vs ZIKV-infected cells.
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Figure 4.3: Nrf2 activation precedes oxidative stress and antagonizes ZIKV
replication. Cells were either mock-infected (M) or infected with ZIKV at MOI 1 and at
the indicated hpi, lysates were prepared and subjected to Western blot analysis to detect
Nrf2, GCLC, G6PD, ZIKV E and β-actin using corresponding antibodies. Relative
electrophoretic mobility of molecular mass markers in kD is shown on the right.
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(Stewart et al., 2003; Tonelli et al., 2018). Subsequent downregulation of Nrf2 at 72 hpi
coincided with the increase in ROS accumulation in A172 cells (Fig. 4.2B and C).
Activation of Nrf2 resulted in concomitant increase in the protein levels of the glutamate
cysteine ligase (GCLC, catalytic subunit) and glucose 6-phosphate (P) dehydrogenase
(G6PD) (Fig. 4.3), whose gene transcription is driven by AREs recognized by Nrf2. The
temporality of increased expression of both GCLC and G6PD was coincident with the
stabilization of Nrf2. Describe data on viral E protein!
While pharmacological activation of Nrf2 has been previously shown to inhibit
ZIKV genome replication (Huang et al., 2017), the effect of Nrf2 depletion in ZIKV
replication has not been determined. siRNA mediated depletion significantly reduced the
levels of Nrf2 in ZIKV infected cells (Fig. 4.4A, lanes 3 and 4). The inability of detecting
Nrf2 in mock-infected cells transfected with siNT or siNrf2 (Fig. 4.4A, lanes 1 and 2) is
consistent with our previous observation (Fig. 4.3). The depletion of Nrf2 also resulted in
reduced expression of both GCLC and G6PD in ZIKV infected cells that were transfected
with siNrf2 in comparison to cells transfected with siNT (Fig. 4.4A, lanes 3 and 4). Nrf2
knockdown increased ZIKV protein expression (Fig. 4.4A). At least a two- to three-fold
increase in E protein expression at 48 hpi was observed in multiple repeat experiments.
Interestingly, infectious virus particle release was significantly increased from cells
depleted of Nrf2 as compared to cells treated with siNT (Fig. 4.4B). The increase in virus
yield ranged from nearly 200-fold at 72 hpi to about 20-fold at 96 hpi with nearly 40-fold
and 70-fold increase at 24 hpi and 48 hpi, respectively (Fig. 4.4B). It should be noted that
the reduced fold-increase in virus titer at 96 hpi is likely due to ZIKV-induced cell death
that we have observed in previous experiments. Furthermore, downregulation of Nrf2
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Figure 4.4: siRNA mediated depletion of Nrf2 enhances ZIKV replication. A Cells
were transfected with either non-targeting (NT) siRNA (siNT) or siRNAs targeting Nrf2
(siNrf2) and mock-infected (M) or infected with ZIKV at MOI 1 and at 48 hpi, lysates
were prepared and subjected to Western blot analysis to detect Nrf2, GCLC, G6PD,
ZIKV E and β-actin using corresponding antibodies. Relative electrophoretic mobility of
molecular mass markers in kD is shown on the right. B Cell culture supernatants from NT
or siNrf2 transfected and ZIKV-infected cells were collected at the indicated times for
quantitation of virus yield by plaque assay. C Cell viability was evaluated by flow
cytometry in siNT or siNrf2 transfected, mock-infected (mock) or ZIKV-infected (ZIKV)
cells at 96 hpi. Error bars represent ± SEM. *, p ≤0.1; **, p ≤0.01; ***, p ≤0.001.
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increased cell death induced by ZIKV (Fig. 4.4C). These results demonstrate that Nrf2
activation counters ZIKV replication and its depletion leads to enhanced replication of
the virus.

4.3.3. Glutathione reduces ZIKV replication and cell death
I next decided to evaluate the role of the antioxidant response triggered by Nrf2
on ZIKV replication. The Nrf-2-dependent increase in GCLC observed upon ZIKV
infection (Fig. 4.4A) suggested a role of glutathione (GSH) synthesis in viral infection, as
GCLC mediates the rate-limiting step in de novo GSH formation by the synthesis of its
precursor, γ-glutamylcysteine (Franco and Cidlowski, 2012). Since I had observed that
ZIKV infection induced GSH depletion (Fig. 4.1E, 4.2D and E) that paralleled the
downregulation of Nrf2/GCLC at 72 hpiobserved after its initial peak between 24-48 hpi
(Fig. 4.3), we examined the effect of buthionine sulfoximine (BSO), an irreversible
inhibitor of GCLC (Franco and Cidlowski, 2012) on ZIKV replication. In the presence of
BSO, ZIKV protein expression was increased approximately 2- to 3-fold (Fig. 4.5A)
while infectious virus yield in the supernatants was significantly enhanced (Fig. 4.5B).
Again, the increase in virus yield ranged from nearly 120-fold at 72 hpi to about 20-fold
at 96 hpi with nearly 80-fold and 85-fold increase at 24 hpi and 48 hpi, respectively, as
compared to BSO-untreated cells. These results correlate well with the results obtained
when Nrf2 is downregulated (Figs. 4.4A and B). Similarly, ZIKV-induced cell death was
also enhanced (Fig. 4.5C). These results demonstrate an antiviral role of Nrf2 via GSH
synthesis in ZIKV infection.
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Figure 4.5: Glutathione reduces ZIKV replication and cell death . A Cells were
mock-infected (M) or infected with ZIKV at MOI 1 followed by treatment with vehicle () or BSO (+) and at 48 hpi, lysates were prepared and subjected to Western blot analysis
to detect ZIKV E and β-actin using corresponding antibodies. Relative electrophoretic
mobility of molecular mass markers in kD is shown on the right. B Cell culture
supernatants from vehicle (ND) or BSO treated, and ZIKV-infected cells were collected
at the indicated times for quantitation of virus yield by plaque assay. C Cell viability was
evaluated by flow cytometry in Vehicle or BSO treated mock-infected (Mock) or ZIKVinfected (ZIKV) cells at 96 hpi. Error bars represent ± SEM. *, p ≤0.1; **, p ≤0.01; ***,
p ≤0.001.
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4.3.4. ZIKV replication is augmented by NADPH depletion
Similar to GCLC, G6PD was transiently upregulated in an Nrf2-dependent
manner during ZIKV replication (Fig. 4.3). G6PD and 6-phosphogluconate
dehydrogenase (6PGD) are NADP-dependent oxidoreductases within the pentose
phosphate pathway (PPP) that regenerate nicotinamide adenine dinucleotide phosphate
(NADPH) whose reductive power fuels numerous antioxidant/reductive systems
(Stanton, 2012). The antioxidant function of GSH is primarily mediated by the activity of
GSH peroxidases (GPx), which catalyze the reduction of peroxides (hydrogen peroxide
[H2O2], peroxynitrite [ONOO-] or lipid peroxides [LOOH]). The resultant GSH disulfide
or oxidized GSH (GSSG) is reduced by GSH reductase (GR) using NADPH as cofactor
(Fig. 4.9) (Franco and Cidlowski, 2012). Because GSH synthesis exerted an inhibitory
effect on ZIKV replication, it was expected that G6PD and 6PGD would also be
inhibitory. In line with this assumption, we found that the depletion of G6PD and 6PGD
enhanced viral protein and infectious virion production (Fig. 4.6A and B). In contrast,
pharmacological inhibition of G6PD and 6PGD by 6-AN significantly inhibited viral
replication (Fig. 4.7A and C). The inhibitory effect 6-AN was not cell specific as it was
also observed in VeroE6 (African green monkey kidney epithelial cells) cells (Fig. 4.7B).
6-AN also inhibited ZIKV-induced cell death (Fig. 4.7D). In addition to its role in
replenishing NADPH pool, the PPP generates ribose 5P, a precursor for the synthesis of
nucleotides. We next explored the possibility that supplementing cells with D-Ribose
under the condition of pharmacologic inhibition of G6PD and 6PGD by 6-AN would
result in rescue of ZIKV replication. Interestingly, even in the presence of D-Ribose, 6-
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Figure 4.6: siRNA mediated depletion of G6PD and 6PGD. A A172 cells were transfected
with either non-targeting (siNT) siRNA or siRNAs targeting G6PD or 6PGD for 48 h and
subsequently mock-infected (M) or infected with ZIKV for 48 h. Cell lysates were prepared and
subjected to Western blot analyses to detect G6PD, 6PGD, ZIKV E and β-actin using the
corresponding antibodies. Relative electrophoretic mobility of molecular mass markers in kD is
shown on the right. B Infectious virus production in cells depleted of G6PD or 6PGD in
comparison to siNT transfected cells. The experiments were conducted as described in panel A,
culture supernatants from infected cells were collected at the indicated hpi and assayed for
infectious virus yield by plaque assay. Horizontal discontinuous line represents limit of detection.
Error bars represent ± SEM. ns, non significant; **, p ≤ 0.01; ***, p ≤ 0.001
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Figure 4.7: 6-AN inhibits ZIKV replication. A A172 B VeroE6 cells were mockinfected (M) or infected with ZIKV at MOI 1 followed by treatment with vehicle (-) or 6AN (+) and at 48 hpi, lysates were prepared and subjected to Western blot analysis to
detect ZIKV E and β-actin using corresponding antibodies. Relative electrophoretic
mobility of molecular mass markers in kD is shown on the right. C Cell culture
supernatants from vehicle (-) or 6-AN (+) treated, and ZIKV-infected cells were collected
at indicated times for quantitation of virus yield by plaque assay. D Cell viability was
evaluated by flow cytometry in vehicle or 6-AN treated and (+) mock-infected (Mock) or
ZIKV-infected (ZIKV) cells at 96 hpi. Error bars represent ± SEM. Ns, non significant;
**, p ≤0.01; ****, p ≤0.0001.
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AN still inhibited ZIKV replication and no rescue of ZIKV protein levels was observed
(Fig. 4.8). Considering the contrasting results obtained by siRNA mediated depletion and
pharmacological inhibition of PPP enzymes, G6PD and 6PGD, it is possible that the
inhibitory effect of 6-AN on ZIKV replication is independent of the PPP and is likely by
hitherto unknown mechanism.

4.4 Discussion
The recent outbreak of ZIKV in the Americas revealed serious neurological and
developmental pathologies in fetuses and adults. The interplay between ZIKV infection
and the resultant induction of oxidative stress in infected cells can contribute to serious
outcomes such congenital defects and developmental abnormalities. Yet a clear
understanding of the molecular mechanisms involved is still absent. This study focused
on the effect of ZIKV infection on the redox homeostasis in neuronal and glial cells.
ZIKV infection of human neuronal progenitor LUHMES cells revealed that these
cells are permissive to virus infection and that ZIKV infection resulted in a significant
increase in the accumulation of ROS. Additionally, a marked reduction of the GSH
content was observed. The presence of higher amounts of reduced GSH in a cell is
indicative of good overall cellular health and a balanced redox state. ZIKV infection
resulted in a significant decrease in the cellular GSH pool indicating oxidative stress
induction and resulting damage. Similarly, infection of human glioblastoma A172 cells
showed accumulation of ROS and a marked decrease in GSH levels signifying oxidative
damage.
Nrf2 is central to the cellular antioxidant system and is known to act as a
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Figure 4.8: Inhibition of ZIKV E expression by 6-ASN is not rescued by D-Ribose.
A172 cells were mock-infected (M) or infected with ZIKV at MOI 1 followed by
treatment with vehicle (-) or 6-AN (+) in the absence (-) or presence (+) of D-Ribose and
at 48 hpi, lysates were prepared and subjected to Western blot analysis to detect ZIKV E
and β-actin using corresponding antibodies. Relative electrophoretic mobility of
molecular mass markers in kD is shown on the right.

95

Figure 4.9: ZIKV induces oxidative stress and activates Nrf2/antioxidant pathway.
ZIKV infection and protein synthesis in infected cells generate oxidative stress that
inhibits the proteasomal degradation of Nrf2 and activates it. Activated Nrf2 directly
modulates the activity of NADPH generating enzymes, G6PD and 6PGD resulting in
higher generation of the reducing power and increasing de novo synthesis of GSH by
modulating the enzyme, GCLC. This leads to the conversion of oxidized GSH (GSSG) to
reduced GSH and increased accumulation of intracellular GSH which maintains redox
homeostasis and prevents ZIKV induced cell death.
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transcription factor inducing the expression of several genes involved in the antioxidant
response carbohydrate metabolism, lipid metabolism as well as de novo glutathione
synthesis and NADPH generation (Hayes and Dinkova-Kostova, 2014). With observation
of oxidative stress induction, we looked for the expression of Nrf2 in ZIKV infected
cells. A transient upregulation of Nrf2 and its downstream effectors, GCLC and G6PD,
was seen upon ZIKV infection with time. The temporality of these events preceded the
marked decrease in cellular GSH pool and the accumulation of ROS. Additionally, with
the depletion of Nrf2, ZIKV replication was enhanced, as was evident with increased
viral protein synthesis and infectious virion production, indicating that the cellular
antioxidant network plays a key role in regulating virus replication. Indeed, inhibition of
de novo GSH synthesis, an important modulator of redox homeostasis in a cell, by BSO
enhanced both ZIKV protein expression and infectious viral progeny titers, corroborating
the observation that cellular antioxidant defense plays an antiviral role in ZIKV
replication. Cellular viability in Nrf2 depleted or BSO treated, ZIKV-infected cells was
also significantly reduced due to increased cell death as a result of virus replication.
Nrf2 directly modulates the cellular reduced GSH pool by regulating key enzymes
that generate the reducing fuel, NADPH. ZIKV infected cells transiently upregulate Nrf2
and its downstream effector, G6PD, which along with 6PGD serves to generate NADPH.
This temporary upregulation leads to increased generation of NADPH that works to
maintain redox homeostasis in the infected cells. Depletion of either G6PD or 6PDG
resulted in the enhancement of viral protein expression and progeny virion production
again corroborating the finding that antioxidant defense system inhibits ZIKV replication.
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It has been reported previously that replication of several different of viruses such
as DENV (Chao et al., 2008), entroviruses (Ho et al., 2008), and coronaviruses (Wu et
al., 2008) is enhanced under conditions of G6PD deficiency. Additionally, individuals
with genetic deficiency in G6PD have been shown to exhibit more severe complications
of hepatitis E virus infection (Au et al., 2011; Thapa et al., 2009). Since G6PD enhances
cellular antiviral response pathways by upregulating certain antiviral genes such as tumor
necrosis factor a (TNF-a) and myxomavirus resistance 1 (MX1) (Wu et al., 2015), G6PD
depletion may downregulate antiviral gene expression and support virus replication more
robustly. Additionally, in G6PD-knowdown cells, expression of HSCARG protein, an
NADPH sensor, has been demonstrated to be upregulated, which in turn has been shown
to enhanced antiviral response. Therefore, it is possible that a combination of redox
imbalance and the inability to generate NADPH and glutathione as well as reduced
antiviral response due to G6PD depletion may contribute to the increased susceptibility to
ZIKV infections.
Interestingly, 6-AN, a known inhibitor of both G6PD or 6PDG did not enhance
ZIKV replication but in stark contrast to siRNA mediated depletion, significantly reduced
ZIKV replication as was evident from viral E protein expression and infectious virus
production. We explored the possibility that supplementing 6-AN treated ZIKV infected
cells with D-Ribose may antagonize the effect of 6-AN and recover ZIKV protein
expression. But it was observed that supplementing 6-AN treated ZIKV infected cells
with D-Ribose did not rescue ZIKV replication, suggesting that the role of PPP is
dispensable for ZIKV replication in these cells. Additionally, the inhibitory effect of 6AN was found to be cell type independent. This suggests that the inhibitory effect of 6-
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AN on ZIKV replication may be by a different mechanism and is not associated with the
downregulation of enzymes involved in PPP such as G6PD and 6GPD. A detailed
exploration into the inhibitory mechanism of 6-AN is essential for it to be developed as
an anti-ZIKV drug. In conclusion, we demonstrate a pivotal role of the Nrf2 signaling
cascade in ZIKV replication and highlights the antiviral nature of the cascade. This
observation may lead to the development of antioxidant supplementation as a strategy to
alleviate ZIKV pathogenesis.
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CHAPTER 5: METABOLIC REGULATION OF ZIKV INFECTION

5.1. Abstract
Virus infection is known to modulate cellular metabolism which drives cellular
energetics to a state conducive to viral replication. Increased rate of glycolysis, enhanced
synthesis of lipids and modifications to lipid membranes, increased production of
nucleotides and enzymatic cofactors, etc. are hallmark metabolic changes in virusinfected cells. Therefore, a better understanding of the specific metabolic changes
induced by virus infection can be useful in the development of antiviral therapies.
Previous studies have revealed that the pentose phosphate pathway does not appear to
play a major role in ZIKV replication. To examine if other cellular pathways namely
glycolysis, gluconeogenesis, or mitochondrial pathways such as fatty acid oxidation,
glutaminolysis, etc are required for the viral replication, we used pharmacologic
inhibitors to determine their effect on ZIKV. Results show that inhibition of the rate
limiting enzyme, hexokinase in the glycolysis pathway, by 2-Deoxy-D-glucose (2-DG), a
glucose analog, reduced viral protein expression and infectious progeny production. The
inhibition by 2-DG recovered transiently at 48 h post-infection. This transient recovery
was prevented when oxidative metabolism was inhibited by blockage of the
mitochondrial pyruvate carrier, inhibition of fatty acid oxidation, or gluaminolysis. These
results suggest that gluconeogenesis plays a role in virus replication. Further studies
examining various metabolites may reveal pathways that are critical for ZIKV
replication.
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5.2. Introduction
The recent re-emergence of ZIKV and the associated serious disease outcomes
such as microcephaly and other neurological deficits in infants and adults poses a major
threat to public health (Faizan et al., 2016). While several reports have studied the
molecular mechanisms involved in the infection, replication, and pathogenesis of ZIKV,
detailed elucidation of ZIKV-induced metabolic changes is not yet available (Jordan and
Randall, 2016; Rothan et al., 2019; Thaker et al., 2019b). Generally, virus infection leads
to enhanced cellular metabolism to meet the biosynthetic needs of viral replication.
Flavivirus replication is known to increase the production of nucleotides and associated
enzymatic cofactors (Jordan and Randall, 2016). DENV infection has been reported to
significantly increase the biosynthesis of carbohydrates, amino acids, and lipids (Fontaine
et al., 2015; Jordan and Randall, 2016). Furthermore, DENV infection also increases
early glycolytic intermediates while decreasing late glycolytic intermediates indicating an
active glycolytic flux (Allonso et al., 2015; Fontaine et al., 2015). Proteomic analysis of
HCV-infected Huh-7.5 cells showed perturbations in cellular metabolic pathways namely
glycolysis, citric acid cycle and the pentose phosphate pathway that favor virus
replication (Diamond et al., 2010). While this happens early in infection, a shift in
cellular metabolism towards cell viability and maintaining energy homeostasis is
observed later in the infection cycle (Diamond et al., 2010).
Glycolysis is also essential for addition of glycan moieties to proteins for
glycosylation, the most common form of post translational modifications (Schjoldager et
al., 2020). Glycosylation of viral proteins is critical to virion assembly, infection as well
as evasion of immune responses (Annamalai et al., 2019; Annamalai et al., 2017;

101

Watanabe et al., 2019). It has been reported that removal of glycosylation sites from the
viral envelope (E) and non-structural protein 1 (NS1) of ZIKV leads to attenuation of
progeny virions and defective in neuroinvasion (Annamalai et al., 2019; Annamalai et al.,
2017; Carbaugh et al., 2019). Furthermore, lipid biosynthesis and intracellular
accumulation of sphingolipids, phospholipids and cholesterol have been shown to
facilitate replication of several prototypic flaviviruses such as WNV and DENV (Heaton
et al., 2010; Mackenzie et al., 2007; Merino-Ramos et al., 2016). DENV activates
autophagy-mediated lipid catabolism and upregulates β-oxidation and energy metabolism
that are essential for efficient virus replication (Heaton and Randall, 2010; Khakpoor et
al., 2009; Lee et al., 2013). Studies with ZIKV have shown that human cells infected with
ZIKV utilize more glucose and feed into the TCA cycle whereas mosquito cells feed into
the pentose phosphate pathway suggesting differential metabolic pathways between
species (Thaker et al., 2019b).
In this study, we demonstrate that the dependency of ZIKV on glycolysis may be
indispensable for optimal viral replication. With pharmacological inhibition of glycolysis
by 2-Deoxy-D-glucose (2-DG), viral protein production and infectious virus yield were
significantly reduced, although a transient increase at 48 hpi was observed. Glycosylated
E protein levels were also reduced suggesting an important role for glycolysis in ZIKV
replication. This observation suggested a virus-induced shift in cellular metabolism
towards gluconeogenesis. We found that with pharmacological inhibition of the
mitochondrial pyruvate carrier, fatty acid oxidation or gluaminolysis, a marked reduction
in viral protein production was noted even at 48 hpi. Taken together, these results suggest
that glycolysis and gluconeogenesis are needed for optimal replication of ZIKV and
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demonstrate the complex dependency of ZIKV on cellular metabolism.

5.3. Results
5.3.1. Glycolysis is necessary for ZIKV protein expression and progeny virion
production
Since virus replication is critically dependent on glycolysis for viral protein
synthesis, post translational modifications of viral proteins, and progeny virion
production (Watanabe et al., 2019),, we sought to first determine the effect of inhibition
of glycolysis on ZIKV replication. By using 2-DG to inhibit the activity of hexokinase,
the enzyme that catalyzes the first irreversible step of the glycolytic pathway where
glucose is phosphorylated to glucose-6-phosphate (G6P), we found a marked decrease in
viral E protein expression across all the time points in comparison to cells infected with
ZIKV and treated with the vehicle (Fig. 5.1A). Interestingly, we observed a transient
increase in the levels of E proteins at 48 hpi (lane 6) but at later times, the E protein
levels were reduced (lanes 8 and 10). Several studies have reported the N-glycosylation
of ZIKV E protein and its importance for viral assembly and infectivity (Annamalai et al.,
2017; Carbaugh et al., 2019; Fontes-Garfias et al., 2017). A follow up study demonstrated
that the major proportion of N-glycan on ZIKV E include N-acetylglucosamine
(GlcNAc) and glucose among others (Routhu et al., 2019). Glucose 6P and Fructose 6P,
two intermediates in glycolytic pathway, are precursors of the nucleotide activated sugars
donors UDP-glucose and UDP-GlcNac, respectively, that mediate protein Nglycosylation. Interestingly, we observed that the inhibition of glycolysis by 2-DG
resulted in the detection of two bands for ZIKV E protein, one representing the fully

103

Figure 5.1: Glycolysis is necessary for ZIKV protein expression and progeny virion
production. A A172 cells were either mock-infected (M) or infected with ZIKV at an
MOI of 1 and treated with vehicle or the glycolytic inhibitor, 2-DG. Cell lysates were
prepared at the indicated hours post-infection (hpi) and subjected to Western blot analysis
to detect ZIKV E and β-actin using the corresponding antibodies. Relative electrophoretic
mobility of molecular mass markers in kD is shown on the right. B Culture supernatants
from vehicle or 2-DG treated and ZIKV-infected cells were collected every 24 hpi for
quantitation of virus yield by plaque assay. #, number of plaques were below the limit of
detection (LOD). **, p≤ 0.01; ****, p≤ 0.0001.
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glycosylated E protein (top band, identified with a black dot on the left of lane 4) and a
faster migrating unglycosylated E protein (bottom band, identified with a red dot on the
left of lane 4) (Fig. 5.1A). The results indicate that exposure of ZIKV infected cells to 2DG leads to significant reduction in viral protein levels but also glycosylation of the viral
E protein.
Since, viral protein levels as well as glycosylation are critical to the production of
infectious progeny virions, we examined the yield of infectious virus in the culture
supernatants of infected cells treated with 2-DG. Results show a dramatic inhibition of
infectious progeny production at all times examined (Fig. 5.1B). Interestingly, at 96 hpi,
when E protein was readily detectable (Fig. 5A, lane 10), infectious progeny was
undetectable (Fig. 5.1B), indicating that factors other than the protein levels or
glycosylation are important for progeny virus production.

5.3.2. Gluconeogenesis partially contributes to ZIKV replication
The transient recovery of ZIKV protein synthesis at 48 hpi under condition of
glycolysis inhibition suggests additional carbon sources are likely fueling viral
replication. Glucose 6P can also be generated by the recycling of phosphoenolpyruvate
via gluconeogenesis, which involves carbon metabolism via the mitochondrial TCA
cycle. Three primary carbon sources can fuel the TCA cycle independent from glycolysis
are (i) pyruvate, originated by either its reverted synthesis from lactate via lactate
dehydrogenase or pyruvate uptake from culture media; (ii) fatty acid oxidation (FAO) to
acetyl-CoA; and (iii3) glutamine lysis (glutaminolysis) to glutamate that is subsequently
incorporated to the TCA cycle upon its metabolism to α-ketoglutarate. Progressive
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oxidation of these carbon sources is coupled to the electron transport chain (ETC). In
addition, reductive carboxylation of pyruvate and glutamine can bypass the ETC to
produce oxaloacetate/malate that can fuel gluconeogenesis as well (Yip et al., 2016).
Therefore, we next evaluated the potential role of mitochondrial metabolism by
inhibiting the ETC complex I by rotenone (ROT) and the mitochondrial pyruvate carrier
by UK5099 (UK). A marginal decrease in the levels of viral E proteins was observed
(Fig. 5.2A). In the presence of ROT or UK, the viral E protein was fully glycosylated
(lanes 7, 8, 11, and 12). Examining NS1, another viral glycoprotein that is critically
involved in genome replication, we observed two species of NS1 (glycosylated and
unglycosylated) in the presence of 2-DG, consistent with our observation with the E
protein. Significant inhibitory effect production of infectious progeny virions was seen
with ROT and UK (Fig. 5.2B). On the other hand, inhibition of FAO by etomoxir (ETO)
and glutaminolysis by BPTES did not produce any significant effect on viral protein
synthesis (Fig. 5.3A) or infectious virus yield (Fig. 5.3B). Interestingly, blocking any of
the pathways that supply carbons to gluconeogenesis under condition of glycolysis
inhibition resulted in reversal of the transient increase in ZIKV protein expression seen at
48 hpi when glycolysis was inhibited (Fig. 5.4A and B). These results indicate that when
glycolysis is inhibited, ZIKV replication is facilitated, albeit in part, by gluconeogenesis.

5.4. Discussion
Viruses have evolved to alter cellular metabolism for creating an environment
optimal for their replication in host cells (Jordan and Randall, 2016). The development of
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Figure 5.2: Inhibition of mitochondrial metabolism affects ZIKV replication. A
A172 cells were either mock-infected (M) or infected with ZIKV at an MOI of 1 and
treated with vehicle or 2-DG or mitochondrial ETC complex I inhibitor, Rotenone (ROT)
or the mitochondrial pyruvate carrier inhibitor, UK5099 (UK). Cell lysates were prepared
at the indicated hours post-infection (hpi) and subjected to Western blot analysis to detect
ZIKV E, NS1, and β-actin using the corresponding antibodies. Relative electrophoretic
mobility of molecular mass markers in kD is shown on the right. B Culture supernatants
from a similar experiment were collected every 24 hpi for quantitation of virus yield by
plaque assay. #, number of plaques were below the limit of detection (LOD). *, p≤ 0.05;
**, p≤ 0.01; ****, p≤ 0.0001.
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Figure 5.3: Inhibition of fatty acid oxidation or glutaminolysis does not affect ZIKV
replication. A A172 cells were either mock-infected (M) or infected with ZIKV at an
MOI of 1 and treated with vehicle or fatty acid oxidation inhibitor, Etomoxir (ETO) or
glutaminolysis inhibitor, BPTES. Cell lysates were prepared at the indicated hours postinfection (hpi) and subjected to Western blot analysis to detect ZIKV E and β-actin using
the corresponding antibodies. Relative electrophoretic mobility of molecular mass
markers in kD is shown on the right. B Culture supernatants from a similar experiment
were collected every 24 hpi for quantitation of virus yield by plaque assay. ns, nonsignificant. Horizontal dashed lines indicated the limit of detection in plaque assay. **,
p≤ 0.01; ****, p≤ 0.0001.
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Figure 5.4: Gluconeogenesis partially regulates ZIKV replication A A172 cells were
either mock-infected (M) or infected with ZIKV at an MOI of 1 and treated with vehicle
or 2-DG along with BPTES or ETO or UK. Cell lysates were prepared at 48 hpi and
subjected to Western blot analysis to detect ZIKV E, NS1, and β-actin using the
corresponding antibodies. Relative electrophoretic mobility of molecular mass markers in
kD is shown on the right. B Culture supernatants from a similar experiment were
collected every 24 hpi for quantitation of virus yield by plaque assay. #, no plaques were
detected.
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metabolomic approaches to study the alterations in cellular metabolism induced by virus
infection have significantly contributed to a better understanding of the role of
metabolism in virus infection, replication as well as pathogenesis (Jordan and Randall,
2016; Sanchez and Lagunoff, 2015). Furthermore, elucidation of specific metabolic
changes induced by specific viruses has led to the development of antiviral strategies
targeting host cell processes (Sanchez and Lagunoff, 2015). In this study, we explored the
role of cellular metabolic pathways and associated signaling cascade in ZIKV protein
expression and replication.
The increase in glycolysis reported in a variety of virus infections demonstrates
the required surge in cellular bioenergetics in infected cells. Increased glycolysis leads to
the generation of nucleotides and other cofactors that are involved in the replication of
the infecting virus. Indeed, in ZIKV infected cells, inhibition of hexokinase, the first
enzyme of glycolysis, by 2-DG, led to a significant loss in viral protein expression and
infectious virus titers indicating a strong dependence of ZIKV on cellular glucose
metabolism. Glycosylation of viral proteins is essential to the production of mature
infectious virus particles and pathogenesis (Annamalai et al., 2019; Annamalai et al.,
2017; Bagdonaite and Wandall, 2018; Watanabe et al., 2019). The downregulation of
viral E and NS1 protein glycosylation status demonstrates a two-fold effect of 2-DG on
inhibition of ZIKV. While blocking the activity of hexokinase by 2-DG reduced ZIKV
replication, a transient increase in the expression of viral E protein as well as infectious
virus yield was observed at 48 hpi. This pointed towards the involvement of other carbon
sources being fed into glucose metabolism via gluconeogenesis (Fig. 5.5).
Standalone inhibition of the ETC complex I by ROT or the mitochondrial
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Figure 5.5: Cellular metabolism and ZIKV replication. Schematic of cellular
metabolism showing glycolysis, PPP, TCA cycle and gluconeogenesis (indicated by blue
arrows). Also shown are the targets for metabolic inhibitors 2-DG, Rotenone (ROT),
Etomoxir (ETO), BPTES, andUK5099 (UK). When glycolysis is blocked by 2-DG,
carbons are cycled into the metabolism from pyruvate, fatty acids and glutamine which
leads to generation of glucose 6P by gluconeogenesis to support ZIKV replication.
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pyruvate carrier by UK led to marginal inhibition of ZIKV protein expression but a more
pronounced effect on infectious progeny production suggesting a contributing role of
mitochondrial metabolism in ZIKV replication. In contrast, standalone inhibition of FAO
by ETO and glutaminolysis by BPTES did not inhibit the accumulation of ZIKV proteins
suggesting the non-involvement of these metabolic processes in ZIKV replication.
Furthermore, when any of above mentioned pathways were blocked under condition of
glycolysis inhibition by 2-DG, the transient increase in ZIKV protein accumulation in
cells was not observed corroborating the finding that gluconeogenesis plays a
contributing role in ZIKV replication.
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CHAPTER 6: SUMMARY, CONCLUSIONS, AND FUTURE DIRECTIONS

6.1 Summary
Viruses are obligate parasites that co-opt the host cell machinery to synthesize
their proteins, replicate their genomes, produce progeny virions, and cause disease. On
the other hand, the host cell also employs several strategies in response to virus infection
that can be pro- or anti-viral in nature. Therefore, studying the alterations in host cell
processes induced by virus infection is key to understanding viral pathogenesis as well as
to the development of antiviral strategies. The studies presented in this dissertation
demonstrate activation of both mTORC1 and mTORC2 upon ZIKV infection and this
facilitates viral protein expression and progeny virion production (Fig 6.1). We also
observed that early in infection, autophagy is activated in ZIKV-infected cells. But later
in the infection process, a gradual decline in autophagy flux was observed which
coincided with the activation of mTORC1. The inhibitory effect of mTORC1 on
autophagy induction was found to be mediated by the phosphorylation of ULK1 (Fig
6.1). These findings point to an antiviral nature of autophagy induction in ZIKV infected
cells that is countered by virus-induced activation of mTORC1. Virus infection is also
known to trigger oxidative stress in infected cells, and this is a critical contributor to
virus-induced pathogenesis. ZIKV infection was found to induce oxidative stress in
infected cells which led to a transient activation of Nrf2 mediated antioxidant response.
Both genetic depletion of Nrf2 and pharmacological inhibition of glutathione (GSH)
synthesis, led to increased expression of viral proteins and infectious virus production
(Fig 6.1). Additionally, downregulation of NADPH generation also increased ZIKV
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Figure 6.1: Host cell responses to ZIKV infection. Nrf2 mediated cellular antioxidant
system negatively regulates ZIKV replication in infected cells as well as counters virus
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infection induced oxidative stress at early time points post infection. But at later time
points, the increased accumulation of viral proteins and replication of ZIKV exerts an
imbalance in the generation and scavenging of oxidants that leads to cellular damage and
cell death (upper part of the illustration). ZIKV replication is dependent on cellular
metabolic processes like glycolysis and gluconeogenesis. Inhibition of glycolysis results
in significant suppression of ZIKV protein expression and infectious virus yield. But a
transient increase is observed at 48 hpi because of the activation of gluconeogenesis
which cycles carbons from sources other than glucose (upper part of the illustration).
ZIKV infection induces the activation of autophagy that degrades viral proteins at early
time points thereby resulting in our ability to not detect them. But at later time points,
activation of the mTORCs phosphorylates ULK1 and suppresses autophagy and this
leads to increased ZIKV protein expression and progeny production (lower part of the
illustration).
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replication, suggesting an anti-viral role of cellular antioxidant system in ZIKV infection.
Viruses are dependent on cellular metabolism and are known to significantly alter
them. We found that ZIKV replication in infected cells is heavily dependent on glycolysis
because the inhibition of glycolysis by 2-DG significantly reduced viral protein
expression and glycosylation as well as infectious virion production (Fig 6.1). We have
also demonstrated that upon inhibition of glycolysis, gluconeogenesis contributes to
ZIKV replication, albeit to a lesser extent. Overall, these findings provide insights into
the molecular mechanisms regarding mTORCs activation, redox homeostasis and
metabolic alterations that are involved in ZIKV infection and replication. The major
conclusions from the above studies are outlined below.

6.2 Conclusions
1. ZIKV infection induced activation of both mTORCs is necessary for viral protein
expression and replication.
2. Autophagy is activated in ZIKV infected cells at early time points post infection
and blockage of autophagy induction favors ZIKV replication.
3. ZIKV induced activation of mTORC1 downregulates autophagy which promotes
ZIKV replication in infected cells.
4. Increased generation of ROS leads to oxidative stress induction in ZIKV infected
cells.
5. Nrf2 mediated cellular antioxidant response plays an antiviral role and inhibits
ZIKV replication.
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6. Cellular GSH and NADPH are critical players in the antioxidant response to
ZIKV infection.
7. Glycolysis is essential to ZIKV protein synthesis and glycosylation and infectious
progeny production.
8. ZIKV replication is partially regulated by gluconeogenesis.

6.3 Future directions
6.3.1 Elucidate the mTOR-independent role of Raptor in ZIKV replication.
Studies reported in chapter 3 of this dissertation show that while depletion of
mTOR kinase resulted in still-detectable levels of ZIKV E protein expression and
progeny production, the siRNA mediated knockdown of Raptor exerted a more robust
negative effect. Therefore, it would be very interesting to explore the molecular
mechanisms involved in the mTOR-independent roles of Raptor in ZIKV replication. We
intend to conduct proteomic analysis of mock- and ZIKV-infected cells and compare the
interactome of Raptor under both conditions. This approach may help me identify unique
proteins other than those involved in the mTOR pathway that Raptor interacts with which
could potentially regulate ZIKV replication.

6.3.2 Which ZIKV proteins are involved in the early activation of autophagy and
late activation of mTORCs?
The molecular mechanisms involved in the activation of autophagy in ZIKV
infected cells are not yet clearly elucidated. While it is shown that NS4A and NS4B
proteins of ZIKV can induce autophagy (Liang et al., 2016), such observations can be

117

dependent on several factors including the cell type, virus strain as well as the duration of
infection. While the studies reported in chapter 3 of this dissertation demonstrate
induction of autophagy early in infection, they do not dissect which viral proteins are
involved in this process. Upon infection, the structural proteins of ZIKV are responsible
for the interaction of the infecting virion with the cell surface receptors and subsequent
internalization. Therefore, it is possible that one or a combination of the structural
proteins or the viral genome itself, upon uncoating, may trigger autophagy in the infected
cell. Furthermore, the role of the other NS proteins in the induction of autophagy cannot
be ruled out. To identify the viral protein(s) that trigger autophagy in ZIKV infected cells,
we intend to study the effect of ectopic expression of each of the viral proteins. Such a
study will help identify the viral protein(s) responsible for the early induction of
autophagy. Additionally, using a similar approach, we plan to identify the viral protein(s)
that interact with the components of the mTOR signaling pathway leading to its
activation. The findings from these studies will significantly contribute to the
understanding of ZIKV induced modulations of cellular signaling pathways.

6.3.3. Explore the effect of ZIKV infection in neuron differentiation using LUHMES
cells.
The human neuronal progenitor LUHMES cells are an interesting and
physiologically relevant model system to study neuron differentiation. These cells can be
differentiated into mature neurons given the right conditions (Scholz et al., 2011). Studies
done in chapter 3 and 4 of this dissertation have shown that ZIKV infection activates
mTOR signaling pathway as well as induces oxidative stress in these cells. While these
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studies were conducted in undifferentiated LUHMES cells, we intend to determine the
effect of ZIKV infection induced activation of mTOR cascade and oxidative stress on
neuronal differentiation and maturation using these cells. By examining specific markers
of mature neuron development from immature progenitor cells, we hope to dissect the
mechanisms involved in ZIKV infection induced pathogenesis.

6.3.4. Study the genes involved in causing microcephaly.
Multiple studies have implicated the involvement of the mTOR signaling pathway
in the regulation of brain development and induction of microcephaly (Cloetta et al.,
2013; Lipton and Sahin, 2014; Thomanetz et al., 2013). It has also been shown that
during brain development, the activation of the mTOR pathway is tightly regulated and
any aberration results in developmental disorders. The MCPH class of proteins (MCPH
1-27) are known to regulate proper neurological development in fetuses (Siskos et al.,
2021). While the direct involvement of mTOR signaling in modulation of these proteins
has not yet been studied, it is possible that ZIKV induced activation of mTORCs
differentially regulates their expression leading to improper brain development and
neurological disease in infants. Additionally, ZIKV infection could alter the relative
levels of these proteins leading to imbalances in the ratios of these proteins that may also
result in microcephaly. Therefore, evaluation of the MCPH group of proteins in ZIKV
infected cells by RNA-seq analysis as well as by Western blotting can be investigated and
a possible link between ZIKV induced activation of the mTOR pathway with the
expression status of the proteins can be established. This will provide important
information on the molecular mechanisms of ZIKV induced microcephaly.
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6.3.5. Mechanism of 6-AN induced inhibition of ZIKV.
The contrasting results obtained by the siRNA mediated depletion and
pharmacological inhibition, by 6-AN, of PPP enzymes G6PD and 6PGD suggests a PPPindependent role of 6-AN in the inhibition of ZIKV replication. 6-AN is known to be
metabolized in cells to 6-amino NAD and 6-amino NADP that act as antimetabolites and
lead to a depletion of cellular pools of NAD and NADP, both of which are essential for
the generation of NADPH. Therefore, it would be interesting to study the cellular
processes, apart from PPP, that are affected by the exposure of cells to 6-AN and how
such processes contribute to the inhibition of ZIKV replication. This will help elucidate
the mechanisms involved inhibition of ZIKV by 6-AN.

6.3.6. Metabolomic analysis to determine the changes in cellular metabolism upon
ZIKV infection.
The experimental findings described in chapter 5 highlight the dependency of
ZIKV on cellular metabolic processes, such glycolysis and gluconeogenesis, for its
replication. While these studies focus on the central carbon metabolism, a holistic
understanding of overall cellular metabolic alterations induced by ZIKV infection is
necessary to better understand the dynamics of host-virus interactions, identify unique
features of virus infection as well as develop novel antiviral strategies. To this end, it
would be interesting to conduct metabolomic analysis of cells infected with ZIKV and
compare the metabolomic profile with that of uninfected cells. Such studies will
significantly contribute to the understanding of host-virus interactions and may provide
novel targets for drugs against ZIKV infections.
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6.3.7. How does cellular GSH antagonize ZIKV?
Studies conducted in chapter 4 show that ZIKV infection causes a Nrf-2dependent increase in GCLC which mediates the rate-limiting step in de novo GSH
formation by the synthesis of its precursor, γ-glutamylcysteine. Cellular GSH is known to
negatively affect the replication of prototypic flaviviruses such as DENV and ZIKV by
inhibiting the activity of viral NS5 protein (Saisawang et al., 2018; Tian et al., 2010).
While such studies have focused on the viral NS5 protein, the effect of glutathionylation
of other viral proteins on virus replication cannot be overlooked. Therefore, we intend to
examine the effect of the redox regulated post translational modification,
glutathionylation, of other ZIKV proteins on viral protein expression and infectious
virion production.
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